DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV
2009-02-04	19107115	Muglia P	2008-12-23	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/19107115	Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts.	Major depressive disorder	1,359 European ancestry cases, 1,782 European ancestry controls	NA	12p13.32	12	4009151	CCND2	LOC105369608 - LOC105369611	105369608	105369611		50544	3876	rs4238010-G	rs4238010	0	4238010	intergenic_variant	1	0.02	6E-6	5.221848749616356		1.72		Affymetrix, Illumina [494678] (imputed)	N
2011-01-04	21042317	Wray NR	2010-11-02	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/21042317	Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned.	Major depressive disorder	2,431 European ancestry cases, 3,673 European ancestry controls	3,332 European ancestry cases, 3,228 European ancestry controls	1q42.11	1	224351238	CNIH4, NVL, WDR26	NVL - CNIH4	4931	29097		21037	5573	rs11579964-C	rs11579964	0	11579964	intergenic_variant	1	0.84	4E-6	5.3979400086720375		1.19	[NR]	Affymetrix, Illumina [1251157] (imputed)	N
2011-01-04	21042317	Wray NR	2010-11-02	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/21042317	Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned.	Major depressive disorder	2,431 European ancestry cases, 3,673 European ancestry controls	3,332 European ancestry cases, 3,228 European ancestry controls	3q27.2	3	185158995	C3orf70, EHHADH	C3orf70 - EHHADH-AS1	285382	339926		5981	3906	rs7647854-G	rs7647854	0	7647854	upstream_gene_variant	1	0.16	5E-6	5.301029995663981		1.19	[NR]	Affymetrix, Illumina [1251157] (imputed)	N
2011-01-04	21042317	Wray NR	2010-11-02	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/21042317	Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned.	Major depressive disorder	2,431 European ancestry cases, 3,673 European ancestry controls	3,332 European ancestry cases, 3,228 European ancestry controls	16q22.3	16	73467637	intergenic	C16orf47			388289			rs12446956-C	rs12446956	0	12446956	intron_variant	0	0.13	1E-6	6.0		1.22	[NR]	Affymetrix, Illumina [1251157] (imputed)	N
2011-01-04	21042317	Wray NR	2010-11-02	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/21042317	Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned.	Major depressive disorder	2,431 European ancestry cases, 3,673 European ancestry controls	3,332 European ancestry cases, 3,228 European ancestry controls	18q12.3	18	43292308	intergenic	SYT4 - LOC105372088	6860	105372088		14658	518386	rs12457996-T	rs12457996	0	12457996	intergenic_variant	1	0.77	6E-6	5.221848749616356		1.15	[NR]	Affymetrix, Illumina [1251157] (imputed)	N
2012-05-11	22472876	Sullivan	2012-04-03	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/22472876	A mega-analysis of genome-wide association studies for major depressive disorder.	Major depressive disorder	9,240 European ancestry cases, 9,519 European ancestry controls	6,783 European ancestry cases, 50,695 European ancestry controls	4q35.2	4	187270152	intergenic	LOC107986335 - LOC339975	107986335	339975		9641	33931	rs4478239-?	rs4478239	0	4478239	intergenic_variant	1	NR	5E-6	5.301029995663981				Affymetrix, Illumina, Perlegen [~ 1200000] (imputed)	N
2012-05-11	22472876	Sullivan	2012-04-03	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/22472876	A mega-analysis of genome-wide association studies for major depressive disorder.	Major depressive disorder	9,240 European ancestry cases, 9,519 European ancestry controls	6,783 European ancestry cases, 50,695 European ancestry controls	16q24.2	16	87428363	MAP1LC3B, ZCCHC14, FBXO31	ZCCHC14			23174			rs9646303-?	rs9646303	0	9646303	intron_variant	0	NR	5E-6	5.301029995663981				Affymetrix, Illumina, Perlegen [~ 1200000] (imputed)	N
2012-05-11	22472876	Sullivan	2012-04-03	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/22472876	A mega-analysis of genome-wide association studies for major depressive disorder.	Major depressive disorder	9,240 European ancestry cases, 9,519 European ancestry controls	6,783 European ancestry cases, 50,695 European ancestry controls	3q21.1	3	122610313	PARP9, DTX3L, PARP15	PARP15			165631			rs2173763-?	rs2173763	0	2173763	intron_variant	0	NR	6E-6	5.221848749616356				Affymetrix, Illumina, Perlegen [~ 1200000] (imputed)	N
2012-05-11	22472876	Sullivan	2012-04-03	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/22472876	A mega-analysis of genome-wide association studies for major depressive disorder.	Major depressive disorder	9,240 European ancestry cases, 9,519 European ancestry controls	6,783 European ancestry cases, 50,695 European ancestry controls	8q23.3	8	115621472	TRPS1	TRPS1			7227			rs2721937-?	rs2721937	0	2721937	intron_variant	0	NR	8E-6	5.096910013008056				Affymetrix, Illumina, Perlegen [~ 1200000] (imputed)	N
2011-06-14	21621269	Aragam N	2011-05-26	J Affect Disord	www.ncbi.nlm.nih.gov/pubmed/21621269	Genome-wide association analysis of gender differences in major depressive disorder in the Netherlands NESDA and NTR population-based samples.	Major depressive disorder	1,726 cases, 1,630 controls	NA	7p14.3	7	31115733	ADCYAP1R1	ADCYAP1R1 - LOC107986780	117	107986780		1728	3310	rs1558477-?	rs1558477	0	1558477	downstream_gene_variant	1		3E-7	6.522878745280337				Perlegen [433556]	N
2011-06-14	21621269	Aragam N	2011-05-26	J Affect Disord	www.ncbi.nlm.nih.gov/pubmed/21621269	Genome-wide association analysis of gender differences in major depressive disorder in the Netherlands NESDA and NTR population-based samples.	Major depressive disorder	1,726 cases, 1,630 controls	NA	2p24.1	2	20061924	LAPTM4A	LOC105373463			105373463			rs7565124-?	rs7565124	0	7565124	downstream_gene_variant	0		2E-6	5.698970004336019				Perlegen [433556]	N
2011-06-14	21621269	Aragam N	2011-05-26	J Affect Disord	www.ncbi.nlm.nih.gov/pubmed/21621269	Genome-wide association analysis of gender differences in major depressive disorder in the Netherlands NESDA and NTR population-based samples.	Major depressive disorder	1,726 cases, 1,630 controls	NA	10p11.22	10	33968684	PARD3	RPL23P11 - PARD3	100271297	56288		103961	140876	rs1780436-?	rs1780436	0	1780436	intergenic_variant	1		3E-6	5.522878745280337				Perlegen [433556]	N
2011-06-14	21621269	Aragam N	2011-05-26	J Affect Disord	www.ncbi.nlm.nih.gov/pubmed/21621269	Genome-wide association analysis of gender differences in major depressive disorder in the Netherlands NESDA and NTR population-based samples.	Major depressive disorder	1,726 cases, 1,630 controls	NA	7q21.11	7	82820719	PCLO	PCLO			27445			rs2715148-?	rs2715148	0	2715148	3_prime_UTR_variant	0		1E-6	6.0				Perlegen [433556]	N
2011-06-14	21621269	Aragam N	2011-05-26	J Affect Disord	www.ncbi.nlm.nih.gov/pubmed/21621269	Genome-wide association analysis of gender differences in major depressive disorder in the Netherlands NESDA and NTR population-based samples.	Major depressive disorder	1,726 cases, 1,630 controls	NA	15q21.1	15	48900594	SHC4	SHC4			399694			rs8023445-?	rs8023445	0	8023445	intron_variant	0		2E-6	5.698970004336019				Perlegen [433556]	N
2010-03-02	20125088	Shi J	2010-02-02	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20125088	Genome-wide association study of recurrent early-onset major depressive disorder.	Major depressive disorder	1,020 European ancestry cases, 1,636 European ancestry controls	NA	18q22.1	18	67618042	DSEL	LOC643542, LOC105372174			643542, 105372174			rs17077540-G	rs17077540	0	17077540	intron_variant	0	0.11	2E-7	6.698970004336019		1.61		Affymetrix [671424]	N
2010-03-02	20125088	Shi J	2010-02-02	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20125088	Genome-wide association study of recurrent early-onset major depressive disorder.	Major depressive disorder	1,020 European ancestry cases, 1,636 European ancestry controls	NA	21q21.2	21	23770802	intergenic	LOC105372749 - LOC105372750	105372749	105372750		61508	41815	rs2828520-G	rs2828520	0	2828520	intergenic_variant	1	0.31	4E-7	6.3979400086720375		1.35		Affymetrix [671424]	N
2010-03-02	20125088	Shi J	2010-02-02	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20125088	Genome-wide association study of recurrent early-onset major depressive disorder.	Major depressive disorder	1,020 European ancestry cases, 1,636 European ancestry controls	NA	5p13.2	5	38051491	GDNF	LOC105374731			105374731			rs270545-G	rs270545	0	270545	intron_variant	0	0.69	1E-6	6.0		1.37		Affymetrix [671424]	N
2010-03-02	20125088	Shi J	2010-02-02	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20125088	Genome-wide association study of recurrent early-onset major depressive disorder.	Major depressive disorder	1,020 European ancestry cases, 1,636 European ancestry controls	NA	1p13.3	1	109577110	GNAT2, GNAI3, AMPD2	GNAI3			2773			rs6537837-T	rs6537837	0	6537837	intron_variant	0	0.17	1E-6	6.0		1.43		Affymetrix [671424]	N
2010-03-02	20125088	Shi J	2010-02-02	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20125088	Genome-wide association study of recurrent early-onset major depressive disorder.	Major depressive disorder	1,020 European ancestry cases, 1,636 European ancestry controls	NA	2p23.2	2	29057895	FAM179A, C2orf71	FAM179A - C2orf71	165186	388939		5665	3795	rs882632-T	rs882632	0	882632	3_prime_UTR_variant	1	0.29	2E-6	5.698970004336019		1.34		Affymetrix [671424]	N
2010-03-02	20125088	Shi J	2010-02-02	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20125088	Genome-wide association study of recurrent early-onset major depressive disorder.	Major depressive disorder	1,020 European ancestry cases, 1,636 European ancestry controls	NA	3p14.2	3	61428140	FHIT, PTPRG	LOC105377114			105377114			rs10514718-C	rs10514718	0	10514718	intergenic_variant	0	0.94	4E-6	5.3979400086720375		2.12		Affymetrix [671424]	N
2010-03-02	20125088	Shi J	2010-02-02	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20125088	Genome-wide association study of recurrent early-onset major depressive disorder.	Major depressive disorder	1,020 European ancestry cases, 1,636 European ancestry controls	NA	7p15.3	7	21464809	SP4	SP4			6671			rs17144465-G	rs17144465	0	17144465	intron_variant	0	0.04	6E-6	5.221848749616356		1.82		Affymetrix [671424]	N
2010-03-02	20125088	Shi J	2010-02-02	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20125088	Genome-wide association study of recurrent early-onset major depressive disorder.	Major depressive disorder	1,020 European ancestry cases, 1,636 European ancestry controls	NA	13q21.33	13	70272071	intergenic	ATXN8OS - RNU6-54P	6315	106478986		132318	187395	rs9572423-G	rs9572423	0	9572423	intergenic_variant	1	0.88	9E-6	5.045757490560675		1.54		Affymetrix [671424]	N
2010-03-02	20125088	Shi J	2010-02-02	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20125088	Genome-wide association study of recurrent early-onset major depressive disorder.	Major depressive disorder	1,020 European ancestry cases, 1,636 European ancestry controls	NA	1p13.3	1	109488566	ATXN7L2, SYPL2, CYB561D1	ATXN7L2			127002			rs12049330-G	rs12049330	0	12049330	intron_variant	0	0.14	6E-6	5.221848749616356		1.44		Affymetrix [671424]	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	5p15.1	5	16812529	MYO10	MYO10			4651			rs17651119-C	rs17651119	0	17651119	intron_variant	0	0.99	2E-8	7.698970004336019	(% improvement - 12 weeks)	3.1807	[2.77-3.59]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	19q13.11	19	33829949	KCTD15	KCTD15 - RN7SL150P	79047	106479276		14188	97415	rs2546057-A	rs2546057	0	2546057	intergenic_variant	1	0.52	3E-7	6.522878745280337	(% improvement - 12 weeks)	1.183	[1.12-1.24]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	1q42.13	1	227480089	intergenic	BTF3P9 - TUBB8P10	503543	391171		45483	12762	rs12410462-A	rs12410462	0	12410462	upstream_gene_variant	1	0.122	4E-7	6.3979400086720375	(% improvement - 12 weeks)	1.259	[1.16-1.36]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	19q13.42	19	55754298	RFPL4A	LOC105372465			105372465			rs17634917-A	rs17634917	0	17634917	upstream_gene_variant	0	0.94	3E-6	5.522878745280337	(% improvement - 12 weeks)	1.371	[1.23-1.51]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	18p11.21	18	10923810	FAM38B	PIEZO2			63895			rs264272-G	rs264272	0	264272	intron_variant	0	0.52	4E-6	5.3979400086720375	(% improvement - 12 weeks)	1.144	[1.09-1.2]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	13q31.1	13	79594869	NDFIP2	LINC01068 - LINC01038	103724388	102724076		23423	209517	rs9601248-C	rs9601248	0	9601248	intergenic_variant	1	0.498	2E-6	5.698970004336019	(remission - 12 weeks)	1.3841	[1.25-1.52]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	4q28.1	4	124344158	intergenic	LOC105377406 - LOC105377408	105377406	105377408		28779	32882	rs2125000-T	rs2125000	0	2125000	regulatory_region_variant	1	0.307	3E-6	5.522878745280337	(remission - 12 weeks)	1.425	[1.27-1.58]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	5q32	5	149657413	FLJ41603	ARHGEF37 - LOC105378224	389337	105378224		22445	45425	rs17710780-T	rs17710780	0	17710780	regulatory_region_variant	1	0.86	4E-6	5.3979400086720375	(remission - 12 weeks)	1.662	[1.45-1.88]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	6p22.3	6	23840904	intergenic	LOC105374976 - LOC100129616	105374976	100129616		214570	13533	rs9466930-C	rs9466930	0	9466930	intergenic_variant	1	0.215	4E-6	5.3979400086720375	(remission - 12 weeks)	1.501	[1.32-1.68]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	12p13.1	12	13488772	GRIN2B	RNU6-590P - GRIN2B	106480593	2904		28996	48565	rs1457614-C	rs1457614	0	1457614	intron_variant	1	0.181	8E-6	5.096910013008056	(remission - 12 weeks)	1.4652	[1.29-1.64]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	15q23	15	68304789	ITGA11	ITGA11			22801			rs7174755-T	rs7174755	0	7174755	intron_variant	0	0.63	9E-7	6.045757490560675	(% improvement - 2 weeks)	1.168	[1.11-1.23]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	5q33.3	5	159580770	MIR548D2	LOC105377684			105377684			rs10065906-C	rs10065906	0	10065906	intron_variant	0	0.332	2E-6	5.698970004336019	(% improvement - 2 weeks)	1.1655	[1.11-1.22]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	5q23.2	5	124496959	intergenic	LINC01170 - ZNF608	103724389	57507		58439	139954	rs12513663-T	rs12513663	0	12513663	intron_variant	1	0.268	2E-6	5.698970004336019	(% improvement - 2 weeks)	1.184	[1.11-1.26]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	3q28	3	192100853	FGF12	RN7SKP222 - FGF12	106479193	2257		7475	38540	rs4585146-G	rs4585146	0	4585146	intergenic_variant	1	0.65	6E-6	5.221848749616356	(% improvement - 2 weeks)	1.1643	[1.11-1.22]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	15q13.3	15	33212866	FMN1	LOC105370759 - TMCO5B	105370759	100652857		8318	23610	rs974379-C	rs974379	0	974379	intergenic_variant	1	0.075	8E-6	5.096910013008056	(% improvement - 2 weeks)	1.2872	[1.17-1.4]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	9q34.13	9	132757106	C9orf98	AK8			158067			rs12552369-A	rs12552369	0	12552369	intron_variant	0	0.494	8E-6	5.096910013008056	(% improvement - 2 weeks)	1.155	[1.1-1.21]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	6p21.1	6	44097574	MRPL14	RPL29P16 - MRPL14	100131206	64928		7811	15880	rs7742824-A	rs7742824	0	7742824	intergenic_variant	1	0.224	9E-6	5.045757490560675	(% improvement - 2 weeks)	1.185	[1.11-1.26]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	5q33.3	5	159580770	intergenic	LOC105377684			105377684			rs10065906-C	rs10065906	0	10065906	intron_variant	0	0.308	5E-8	7.301029995663981	(partial response - 2 weeks)	1.4712	[1.33-1.61]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	2q32.3	2	192877447	intergenic	PCGEM1 - LOC107985969	64002	107985969		100548	172936	rs10174573-T	rs10174573	0	10174573	intergenic_variant	1	0.57	2E-6	5.698970004336019	(partial response - 2 weeks)	1.564	[1.39-1.74]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	5q31.3	5	141831188	PCDH1	LOC107986454 - PCDH1	107986454	5097		2376	21131	rs166040-G	rs166040	0	166040	upstream_gene_variant	1	0.87	5E-6	5.301029995663981	(partial response - 2 weeks)	1.6054	[1.41-1.8]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	12p12.3	12	17509301	intergenic	TIMM17BP1 - LOC105369678	390298	105369678		108110	75144	rs1706631-T	rs1706631	0	1706631	downstream_gene_variant	1	0.408	6E-6	5.221848749616356	(partial response - 2 weeks)	1.3548	[1.22-1.49]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	4p15.2	4	24739335	SOD3	LOC107986266 - HNRNPA1P65	107986266	106481664		67761	32072	rs12500612-G	rs12500612	0	12500612	intergenic_variant	1	0.85	7E-6	5.154901959985743	(partial response - 2 weeks)	1.7665	[1.51-2.02]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	13q14.11	13	43260134	ENOX1	ENOX1			55068			rs17538444-T	rs17538444	0	17538444	intron_variant	0	0.0698752	4E-7	6.3979400086720375	(% improvement - SSRI treated - 12 weeks)	0.3905	[0.24-0.54] unit decrease	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	22q12.3	22	34427837	ENOX1	LOC105373012 - LOC441996	105373012	441996		65524	160917	rs1034394-G	rs1034394	0	1034394	intergenic_variant	1	0.3390146	2E-6	5.698970004336019	(% improvement - SSRI treated - 12 weeks)	0.2107	[0.12-0.3] unit increase	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	18p11.21	18	10923810	FAM38B	PIEZO2			63895			rs264272-T	rs264272	0	264272	intron_variant	0	0.4874733	3E-6	5.522878745280337	(% improvement - SSRI treated - 12 weeks)	0.1712	[0.099-0.243] unit decrease	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	15q26.3	15	99759034	LYSMD4, C15orf51	LYSMD4 - LOC105371020	145748	105371020		25473	11808	rs6598266-A	rs6598266	0	6598266	intergenic_variant	1	0.1427493	3E-6	5.522878745280337	(% improvement - SSRI treated - 12 weeks)	0.2543	[0.15-0.36] unit increase	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	19q13.11	19	33830353	KCTD15, CHST8	KCTD15 - RN7SL150P	79047	106479276		14592	97011	rs398426-T	rs398426	0	398426	intergenic_variant	1	0.2588456	5E-6	5.301029995663981	(% improvement - SSRI treated - 12 weeks)	0.2513	[0.14-0.36] unit decrease	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	19q13.42	19	55754298	EPN1, NLRP9, NLRP11, RFPL4A	LOC105372465			105372465			rs17634917-G	rs17634917	0	17634917	upstream_gene_variant	0	0.0573945	6E-6	5.221848749616356	(% improvement - SSRI treated - 12 weeks)	0.3761	[0.21-0.54] unit decrease	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	4q28.1	4	124494379	intergenic	TECRP2 - LOC101927087	391696	101927087		30519	5563	rs6534441-C	rs6534441	0	6534441	intergenic_variant	1	0.3328325	7E-6	5.154901959985743	(% improvement - SSRI treated - 12 weeks)	0.1801	[0.1-0.26] unit decrease	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	13q31.1	13	80783536	intergenic	LOC105377818			105377818			rs11149178-A	rs11149178	0	11149178	intergenic_variant	0	0.3560899	7E-6	5.154901959985743	(% improvement - SSRI treated - 12 weeks)	0.1777	[0.1-0.26] unit decrease	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	12p13.32	12	4307138	C12orf5, CCND2	CCND2 - C12orf5	894	57103		1782	14055	rs4625554-G	rs4625554	0	4625554	upstream_gene_variant	1	0.2996789	9E-6	5.045757490560675	(% improvement - SSRI treated - 12 weeks)	0.1927	[0.11-0.28] unit increase	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	7q11.22	7	71008019	WBSCR17	LOC100967223 - WBSCR17	100967223	64409		162666	124395	rs1525293-C	rs1525293	0	1525293	intergenic_variant	1	0.66	2E-6	5.698970004336019	(remission - SSRI treated - 12 weeks)	1.7041	[1.48-1.92]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	9p24.3	9	955794	DMRT3, DMRT1	DMRT1			1761			rs364477-C	rs364477	0	364477	intron_variant	0	0.2154931	4E-6	5.3979400086720375	(remission - SSRI treated - 12 weeks)	1.6925	[1.47-1.92]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	14q23.2	14	62855629	KCNH5	KCNH5			27133			rs8012941-G	rs8012941	0	8012941	intron_variant	0	0.4975174	4E-6	5.3979400086720375	(remission - SSRI treated - 12 weeks)	1.5387	[1.35-1.72]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	12p13.1	12	13367062	C12orf36	EMP1 - LINC01559	2012	283422		150288	3609	rs11055387-C	rs11055387	0	11055387	downstream_gene_variant	1	0.0895145	8E-6	5.096910013008056	(remission - SSRI treated - 12 weeks)	2.1853	[1.84-2.53]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	1q41	1	217027541	ESRRG	ESRRG			2104			rs2377360-G	rs2377360	0	2377360	intron_variant	0	0.2632403	9E-6	5.045757490560675	(remission - SSRI treated - 12 weeks)	1.6	[1.39-1.81]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	5p14.1	5	27611324	intergenic	LINC01021 - LOC105374696	643401	105374696		114923	161007	rs12054895-T	rs12054895	0	12054895	intergenic_variant	1	0.275456	3E-8	7.522878745280337	(% improvement - SSRI treated - 2 weeks)	0.2428	[0.16-0.33] unit increase	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	15q23	15	68304789	PIAS1, CALML4, CLN6, FEM1B, ITGA11	ITGA11			22801			rs7174755-C	rs7174755	0	7174755	intron_variant	0	0.3690476	3E-7	6.522878745280337	(% improvement - SSRI treated - 2 weeks)	0.2048	[0.13-0.28] unit decrease	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	3q28	3	192100853	FGF12	RN7SKP222 - FGF12	106479193	2257		7475	38540	rs4585146-A	rs4585146	0	4585146	intergenic_variant	1	0.362271	3E-7	6.522878745280337	(% improvement - SSRI treated - 2 weeks)	0.2208	[0.14-0.31] unit decrease	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	19q13.11	19	32598525	PDCD5, ANKRD27, RGS9BP, NUDT19	ANKRD27			84079			rs17692896-A	rs17692896	0	17692896	intron_variant	0	0.0739179	7E-7	6.154901959985743	(% improvement - SSRI treated - 2 weeks)	0.4395	[0.27-0.61] unit decrease	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	6p22.3	6	16255812	MYLIP, GMPR, ATXN1	GMPR			2766			rs10484358-T	rs10484358	0	10484358	intron_variant	0	0.0827112	1E-6	6.0	(% improvement - SSRI treated - 2 weeks)	0.4258	[0.25-0.6] unit decrease	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	5q14.3	5	87738535	RASA1, CCNH	LOC105379069 - LOC105379070	105379069	105379070		171	360863	rs1673101-A	rs1673101	0	1673101	intergenic_variant	1	0.3312154	4E-6	5.3979400086720375	(% improvement - SSRI treated - 2 weeks)	0.1877	[0.11-0.27] unit decrease	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	1p36.32	1	5294784	intergenic	LOC105376682 - LOC107984911	105376682	107984911		159473	175545	rs912988-T	rs912988	0	912988	intergenic_variant	1	0.3630374	6E-6	5.221848749616356	(% improvement - SSRI treated - 2 weeks)	0.1825	[0.1-0.26] unit increase	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	3q29	3	193865921	intergenic	LOC105374287			105374287			rs604222-A	rs604222	0	604222	intergenic_variant	0	0.1915251	7E-6	5.154901959985743	(% improvement - SSRI treated - 2 weeks)	0.2173	[0.12-0.31] unit increase	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	3q25.33	3	159926508	IL12A, SCHIP1	IL12A-AS1			101928376			rs6799788-G	rs6799788	0	6799788	intron_variant	0	0.2476976	1E-6	6.0	(partial response - SSRI treated - 2 weeks)	1.6268	[1.43-1.82]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	5q33.3	5	159580770	MIR548D2	LOC105377684			105377684			rs10065906-C	rs10065906	0	10065906	intron_variant	0	0.3622876	2E-6	5.698970004336019	(partial response - SSRI treated - 2 weeks)	1.5298	[1.36-1.7]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	4q21.22	4	81541443	RASGEF1B	LOC105377306 - LOC107986215	105377306	107986215		39301	167404	rs1822818-T	rs1822818	0	1822818	intron_variant	1	0.87	6E-6	5.221848749616356	(partial response - SSRI treated - 2 weeks)	1.7737	[1.53-2.02]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	6p24.3	6	10175803	intergenic	LOC107983965			107983965			rs12210761-A	rs12210761	0	12210761	intron_variant	0	0.0676606	6E-6	5.221848749616356	(partial response - SSRI treated - 2 weeks)	2.4458	[2.06-2.83]	Affymetrix, Illumina [1200000] (imputed)	N
2013-05-09	23377640	GENDEP Investigators	2013-02-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23377640	Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.	Major depressive disorder	Up to 2,256 European ancestry cases	NA	7p12.3	7	45942861	IGFBP1, IGFBP3	LOC102723446			102723446			rs2462686-C	rs2462686	0	2462686	intergenic_variant	0	0.3509068	9E-6	5.045757490560675	(partial response - SSRI treated - 2 weeks)	1.4872	[1.31-1.66]	Affymetrix, Illumina [1200000] (imputed)	N
2014-02-04	23857890	Power RA	2013-07-15	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/23857890	Genome-wide association analysis accounting for environmental factors through propensity-score matching: application to stressful live events in major depressive disorder.	Major depressive disorder	805 European ancestry cases, 805 European ancestry controls	NA	16q24.1	16	86070536	IRF8	LOC105376778 - LINC01082	105376778	100506542		10330	125645	rs8050326-A	rs8050326	0	8050326	intergenic_variant	1	0.44	3E-7	6.522878745280337		1.45	[1.26-1.76]	Illumina [457670]	N
2014-02-04	23857890	Power RA	2013-07-15	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/23857890	Genome-wide association analysis accounting for environmental factors through propensity-score matching: application to stressful live events in major depressive disorder.	Major depressive disorder	805 European ancestry cases, 805 European ancestry controls	NA	18q21.32	18	59647575	CCBE1	CCBE1			147372			rs11152166-?	rs11152166	0	11152166	intron_variant	0	0.58	3E-6	5.522878745280337		1.41	[1.22-1.61]	Illumina [457670]	N
2017-08-09	28540843	Mbarek H	2017-05-25	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/28540843	Genome-Wide Significance for PCLO as a Gene for Major Depressive Disorder.	Major depressive disorder	1,942 European ancestry cases, 4,565 European ancestry controls	NA	7q21.11	7	82839058	PCLO	PCLO			27445			rs2715157-?	rs2715157	0	2715157	intron_variant	0	0.52	3E-8	7.522878745280337		1.27	[1.16-1.37]	Affymetrix [NR] (imputed)	N
2017-09-18	28696415	Maciukiewicz M	2017-07-11	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/28696415	Genome-wide association studies of placebo and duloxetine response in major depressive disorder.	Duloxetine response in major depressive disorder (% change in symptom score)	186 European ancestry individuals	NA	3p26.1	3	5645577	MIR4790	MRPS35P1 - LOC105376939	339910	105376939		198474	38720	rs4685959-?	rs4685959	0	4685959	intergenic_variant	1		1E-6	6.0		1.1	[NR] unit decrease	Illumina [1924595] (imputed)	N
2017-09-18	28696415	Maciukiewicz M	2017-07-11	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/28696415	Genome-wide association studies of placebo and duloxetine response in major depressive disorder.	Duloxetine response in major depressive disorder (% change in symptom score)	186 European ancestry individuals	NA	4p15.31	4	18291521	ATP8A1	LOC107986262 - LOC105374510	107986262	105374510		64756	120268	rs13147572-?	rs13147572	0	13147572	intergenic_variant	1		8E-6	5.096910013008056		0.44	[NR] unit decrease	Illumina [1924595] (imputed)	N
2017-09-18	28696415	Maciukiewicz M	2017-07-11	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/28696415	Genome-wide association studies of placebo and duloxetine response in major depressive disorder.	Placebo response in major depressive disorder (% change in symptom score)	205 European ancestry individuals	NA	3p22.3	3	36230378	STAC1	RFC3P1 - STAC	100131711	6769		59891	150077	rs76767803-?	rs76767803	0	76767803	intergenic_variant	1		1E-8	8.0		0.69	[NR] unit increase	Illumina [1924595] (imputed)	N
2017-09-18	28696415	Maciukiewicz M	2017-07-11	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/28696415	Genome-wide association studies of placebo and duloxetine response in major depressive disorder.	Placebo response in major depressive disorder (% change in symptom score)	205 European ancestry individuals	NA	2p25.3	2	1550418	TPO	LOC102723730			102723730			rs78456975-?	rs78456975	0	78456975	intron_variant	0		3E-6	5.522878745280337		0.59	[NR] unit increase	Illumina [1924595] (imputed)	N
2012-05-11	22472876	Sullivan	2012-04-03	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/22472876	A mega-analysis of genome-wide association studies for major depressive disorder.	Major depressive disorder	9,240 European ancestry cases, 9,519 European ancestry controls	6,783 European ancestry cases, 50,695 European ancestry controls	3q27.1	3	184158724	HTR3D, HTR3C, HTR3E, EIF2B5, ECE2, DVL3, AP2M1, ABCF3, VWA5B2, MIR1224, ALG3, CAMK2N2	DVL3			1857			rs1969253-?	rs1969253	0	1969253	intron_variant	0	NR	5E-6	5.301029995663981				Affymetrix, Illumina, Perlegen [~ 1200000] (imputed)	N
2017-01-24	27519822	Power RA	2016-05-24	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27519822	Genome-wide Association for Major Depression Through Age at Onset Stratification: Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium.	Major depressive disorder	3,869 European ancestry 50% oldest-onset cases, 5,051 European ancestry cases, 2,691 European ancestry controls, 6,828 unknown controls	6,107 European ancestry, Han Chinese ancestry and unknown ancestry 50% oldest-onset cases, 7,131 European ancestry, Han Chinese ancestry and unknown ancestry cases, 104,402 European ancestry controls, 5,537 Han Chinese ancestry controls, 14,291 unknown ancestry controls	3q27.2	3	185158995	C3orf70, VPS8, EHHADH, MAP3K13	C3orf70 - EHHADH-AS1	285382	339926		5981	3906	rs7647854-G	rs7647854	0	7647854	upstream_gene_variant	1	0.16	5E-11	10.301029995663981	(50% oldest-onset cases)	1.16	[1.11-1.21]	NR [1235109] (imputed)	N
2012-07-11	22584459	Sasayama D	2012-05-15	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/22584459	Possible association of CUX1 gene polymorphisms with antidepressant response in major depressive disorder.	Response to antidepressants	92 Japanese ancestry cases	136 Japanese ancestry cases	7q22.1	7	102166571	CUX1	CUX1			1523			rs365836-A	rs365836	0	365836	intron_variant	0	NR	2E-6	5.698970004336019		4.79	[2.38-9.64]	Illumina [291512]	N
2010-04-15	20351715	Liu Y	2010-03-30	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20351715	Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.	Bipolar disorder or major depressive disorder (combined)	4,387 European ancestry bipolar cases, 1,695 European ancestry major depressive disorder cases, 7,970 European ancestry controls	NA	4q28.1	4	125438301	FAT4	FAT4			79633			rs1395241-?	rs1395241	0	1395241	intron_variant	0	NR	8E-6	5.096910013008056				Affymetrix, Perlegen [1472580] (imputed)	N
2010-04-15	20351715	Liu Y	2010-03-30	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20351715	Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.	Bipolar disorder or major depressive disorder (combined)	4,387 European ancestry bipolar cases, 1,695 European ancestry major depressive disorder cases, 7,970 European ancestry controls	NA	15q14	15	38694167	C15orf53	LOC105370775 - C15orf53	105370775	400359		4912	2431	rs12912251-?	rs12912251	0	12912251	upstream_gene_variant	1	NR	1E-6	6.0				Affymetrix, Perlegen [1472580] (imputed)	N
2010-04-15	20351715	Liu Y	2010-03-30	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20351715	Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.	Bipolar disorder or major depressive disorder (combined)	4,387 European ancestry bipolar cases, 1,695 European ancestry major depressive disorder cases, 7,970 European ancestry controls	NA	7q21.12	7	87192664	C7orf23, DMTF1	DMTF1			9988			rs11773103-?	rs11773103	0	11773103	non_coding_transcript_exon_variant	0	NR	1E-6	6.0				Affymetrix, Perlegen [1472580] (imputed)	N
2010-04-15	20351715	Liu Y	2010-03-30	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20351715	Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.	Bipolar disorder or major depressive disorder (combined)	4,387 European ancestry bipolar cases, 1,695 European ancestry major depressive disorder cases, 7,970 European ancestry controls	NA	12p13.33	12	2236129	CACNA1C	CACNA1C			775			rs1006737-?	rs1006737	0	1006737	intron_variant	0	NR	3E-8	7.522878745280337				Affymetrix, Perlegen [1472580] (imputed)	N
2010-04-15	20351715	Liu Y	2010-03-30	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20351715	Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.	Bipolar disorder or major depressive disorder (combined)	4,387 European ancestry bipolar cases, 1,695 European ancestry major depressive disorder cases, 7,970 European ancestry controls	NA	6q25.2	6	152417619	SYNE1	SYNE1			23345			rs17082664-?	rs17082664	0	17082664	intron_variant	0	NR	1E-6	6.0				Affymetrix, Perlegen [1472580] (imputed)	N
2010-04-15	20351715	Liu Y	2010-03-30	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20351715	Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.	Bipolar disorder or major depressive disorder (combined)	4,387 European ancestry bipolar cases, 1,695 European ancestry major depressive disorder cases, 7,970 European ancestry controls	NA	13q14.3	13	50492487	intergenic	DLEU1			10301			rs1262778-?	rs1262778	0	1262778	intron_variant	0	NR	8E-6	5.096910013008056				Affymetrix, Perlegen [1472580] (imputed)	N
2010-04-15	20351715	Liu Y	2010-03-30	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20351715	Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.	Bipolar disorder or major depressive disorder (combined)	4,387 European ancestry bipolar cases, 1,695 European ancestry major depressive disorder cases, 7,970 European ancestry controls	NA	10q21.2	10	60421370	ANK3	ANK3			288			rs10994338-?	rs10994338	0	10994338	intron_variant	0	NR	5E-7	6.301029995663981				Affymetrix, Perlegen [1472580] (imputed)	N
2010-04-15	20351715	Liu Y	2010-03-30	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20351715	Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.	Bipolar disorder or major depressive disorder (combined)	4,387 European ancestry bipolar cases, 1,695 European ancestry major depressive disorder cases, 7,970 European ancestry controls	NA	18p11.32	18	278796	COLEC12, THOC1	THOC1 - COLEC12	9984	81035		10737	40559	rs7226677-?	rs7226677	0	7226677	regulatory_region_variant	1	NR	4E-6	5.3979400086720375				Affymetrix, Perlegen [1472580] (imputed)	N
2010-04-15	20351715	Liu Y	2010-03-30	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20351715	Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.	Bipolar disorder or major depressive disorder (combined)	4,387 European ancestry bipolar cases, 1,695 European ancestry major depressive disorder cases, 7,970 European ancestry controls	NA	2q31.1	2	175375121	intergenic	RPS15AP14 - LOC105373752	100127924	105373752		190466	79485	rs4972755-?	rs4972755	0	4972755	intron_variant	1	NR	3E-6	5.522878745280337				Affymetrix, Perlegen [1472580] (imputed)	N
2010-09-10	20673876	Rietschel M	2010-07-29	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20673876	Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression.	Major depressive disorder	597 European ancestry cases, 1,295 European ancestry controls	409 European ancestry cases, 541 European ancestry controls	5q14.1	5	79533426	HOMER1	RPL7AP32 - LOC105379047	133748	105379047		3275	14147	rs7713917-G	rs7713917	0	7713917	upstream_gene_variant	1	0.60	1E-6	6.0		1.33	[1.19-1.49]	Illumina [491238]	N
2010-09-10	20673876	Rietschel M	2010-07-29	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20673876	Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression.	Major depressive disorder	597 European ancestry cases, 1,295 European ancestry controls	409 European ancestry cases, 541 European ancestry controls	12q15	12	68976976	CPM	CPM - LOC107984471	1368	107984471		13736	30683	rs9943849-T	rs9943849	0	9943849	intergenic_variant	1	0.73	3E-6	5.522878745280337		1.37	[1.20-1.56]	Illumina [491238]	N
2010-09-10	20673876	Rietschel M	2010-07-29	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20673876	Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression.	Major depressive disorder	597 European ancestry cases, 1,295 European ancestry controls	409 European ancestry cases, 541 European ancestry controls	15q14	15	36021764	intergenic	LOC105370766 - LOC100507480	105370766	100507480		45594	24078	rs10520045-T	rs10520045	0	10520045	intron_variant	1	0.27	7E-6	5.154901959985743		1.32	[1.17-1.50]	Illumina [491238]	N
2014-01-07	21041247	Perlis RH	2010-11-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/21041247	Genome-wide association study of suicide attempts in mood disorder patients.	Suicide risk	3,117 European ancestry Bipolar disorder cases, 1,273 European ancestry Major depressive disorder cases	2,698 European ancestry Bipolar disorder cases, 1,649 Major depressive disorder cases	10q24.1	10	95362484	PDLIM1, SORBS1	SORBS1			10580			rs4918918-T	rs4918918	0	4918918	intron_variant	0	NR	3E-6	5.522878745280337		1.18		Affymetrix [1922309] (imputed)	N
2014-01-07	21041247	Perlis RH	2010-11-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/21041247	Genome-wide association study of suicide attempts in mood disorder patients.	Suicide risk	3,117 European ancestry Bipolar disorder cases, 1,273 European ancestry Major depressive disorder cases	2,698 European ancestry Bipolar disorder cases, 1,649 Major depressive disorder cases	21q22.2	21	39649825	IGSF5, B3GALT5	B3GALT5			10317			rs10854398-C	rs10854398	0	10854398	intron_variant	0	NR	6E-6	5.221848749616356		1.178		Affymetrix [1922309] (imputed)	N
2014-01-07	21041247	Perlis RH	2010-11-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/21041247	Genome-wide association study of suicide attempts in mood disorder patients.	Suicide risk	3,117 European ancestry Bipolar disorder cases, 1,273 European ancestry Major depressive disorder cases	2,698 European ancestry Bipolar disorder cases, 1,649 Major depressive disorder cases	10p11.23	10	30201775	PRKCE	LOC105376477			105376477			rs2462021-C	rs2462021	0	2462021	intergenic_variant	0	NR	8E-6	5.096910013008056		1.1755		Affymetrix [1922309] (imputed)	N
2014-01-07	21041247	Perlis RH	2010-11-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/21041247	Genome-wide association study of suicide attempts in mood disorder patients.	Suicide risk	3,117 European ancestry Bipolar disorder cases, 1,273 European ancestry Major depressive disorder cases	2,698 European ancestry Bipolar disorder cases, 1,649 Major depressive disorder cases	2p21	2	46093955	intergenic	PRKCE			5581			rs12373805-A	rs12373805	0	12373805	intron_variant	0	NR	9E-6	5.045757490560675		1.2169		Affymetrix [1922309] (imputed)	N
2011-06-01	21521612	Kohli MA	2011-04-28	Neuron	www.ncbi.nlm.nih.gov/pubmed/21521612	The neuronal transporter gene SLC6A15 confers risk to major depression.	Major depressive disorder	353 European ancestry cases, 366 European ancestry controls	991 African Americans, 4,308 European ancestry cases, 9,661 European ancestry controls	12q21.31	12	84170289	SLC6A15	LOC107984536			107984536			rs1545843-A	rs1545843	0	1545843	intergenic_variant	0	NR	1E-9	9.0		1.398	[1.254-1.557]	Illumina [365676]	N
2010-01-19	20038947	Shyn SI	2009-12-29	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20038947	Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.	Major depressive disorder (broad)	3,957 European ancestry cases, 3,428 European ancestry controls	NA	8p21.3	8	20208538	SLC18A1, ATP6V1B2, LZTS1	ATP6V1B2			526			rs1106634-A	rs1106634	0	1106634	intron_variant	0	0.14	7E-7	6.154901959985743		1.3	[NR]	Affymetrix, Perlegen [2391203] (imputed)	N
2010-01-19	20038947	Shyn SI	2009-12-29	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20038947	Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.	Major depressive disorder (broad)	3,957 European ancestry cases, 3,428 European ancestry controls	NA	7p15.3	7	21464809	SP4	SP4			6671			rs17144465-G	rs17144465	0	17144465	intron_variant	0	0.03	8E-7	6.096910013008056		1.56	[NR]	Affymetrix, Perlegen [2391203] (imputed)	N
2010-01-19	20038947	Shyn SI	2009-12-29	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20038947	Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.	Major depressive disorder (broad)	3,957 European ancestry cases, 3,428 European ancestry controls	NA	3p26.1	3	7487868	GRM7	GRM7			2917			rs9870680-T	rs9870680	0	9870680	intron_variant	0	0.44	1E-6	6.0		1.19	[NR]	Affymetrix, Perlegen [2391203] (imputed)	N
2010-01-19	20038947	Shyn SI	2009-12-29	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20038947	Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.	Major depressive disorder (broad)	3,957 European ancestry cases, 3,428 European ancestry controls	NA	7q32.3	7	131215362	AK294384	MKLN1			4289			rs10265216-A	rs10265216	0	10265216	intron_variant	0	0.28	3E-6	5.522878745280337		1.19	[NR]	Affymetrix, Perlegen [2391203] (imputed)	N
2010-01-19	20038947	Shyn SI	2009-12-29	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20038947	Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.	Major depressive disorder (broad)	3,957 European ancestry cases, 3,428 European ancestry controls	NA	3q26.32	3	177573909	NR	LINC00578			100505566			rs644695-A	rs644695	0	644695	intron_variant	0	0.88	5E-6	5.301029995663981		1.35	[NR]	Affymetrix, Perlegen [2391203] (imputed)	N
2010-01-19	20038947	Shyn SI	2009-12-29	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20038947	Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.	Major depressive disorder (broad)	3,957 European ancestry cases, 3,428 European ancestry controls	NA	2p14	2	67715348	BC043421	LOC105374786 - LOC101927701	105374786	101927701		64318	80706	rs724568-C	rs724568	0	724568	intergenic_variant	1	0.36	5E-6	5.301029995663981		1.17	[NR]	Affymetrix, Perlegen [2391203] (imputed)	N
2010-01-19	20038947	Shyn SI	2009-12-29	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20038947	Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.	Major depressive disorder (broad)	3,957 European ancestry cases, 3,428 European ancestry controls	NA	Xq21.33	X	95824871	NR	LOC100420872 - LOC648927	100420872	648927		103727	148263	rs5990417-T	rs5990417	0	5990417	intergenic_variant	1	0.83	6E-6	5.221848749616356		1.23	[NR]	Affymetrix, Perlegen [2391203] (imputed)	N
2010-01-19	20038947	Shyn SI	2009-12-29	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20038947	Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.	Major depressive disorder (broad)	3,957 European ancestry cases, 3,428 European ancestry controls	NA	6p25.1	6	6612234	LY86	LY86-AS1, LY86			285780, 9450			rs2326810-G	rs2326810	0	2326810	intron_variant	0	0.92	7E-6	5.154901959985743		1.41	[NR]	Affymetrix, Perlegen [2391203] (imputed)	N
2010-01-19	20038947	Shyn SI	2009-12-29	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20038947	Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.	Major depressive disorder (broad)	3,957 European ancestry cases, 3,428 European ancestry controls	NA	10p12.1	10	29002969	NR	RPL21P93 - LOC107984174	653665	107984174		103445	55086	rs1612122-T	rs1612122	0	1612122	intergenic_variant	1	0.48	7E-6	5.154901959985743		1.17	[NR]	Affymetrix, Perlegen [2391203] (imputed)	N
2010-06-21	20516156	Lewis CM	2010-06-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20516156	Genome-wide association study of major recurrent depression in the U.K. population.	Major depressive disorder	1,636 European ancestry cases, 1,594 European ancestry controls	1,418 European ancestry cases, 1,918 European ancestry controls	1q31.3	1	193952418	LOC647167	RPL23AP22 - LOC107985242	100271291	107985242		195151	205727	rs606149-?	rs606149	0	606149	intergenic_variant	1	0.46	3E-6	5.522878745280337		1.25	[NR]	Illumina [471747]	N
2010-06-21	20516156	Lewis CM	2010-06-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20516156	Genome-wide association study of major recurrent depression in the U.K. population.	Major depressive disorder	1,636 European ancestry cases, 1,594 European ancestry controls	1,418 European ancestry cases, 1,918 European ancestry controls	5q14.3	5	83594091	VCAN	VCAN - HAPLN1	1462	1404		11788	44107	rs310501-?	rs310501	0	310501	intergenic_variant	1	0.33	7E-6	5.154901959985743		1.16	[NR]	Illumina [471747]	N
2010-06-21	20516156	Lewis CM	2010-06-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20516156	Genome-wide association study of major recurrent depression in the U.K. population.	Major depressive disorder	1,636 European ancestry cases, 1,594 European ancestry controls	1,418 European ancestry cases, 1,918 European ancestry controls	3q26.31	3	174311255	NLGN1	NLGN1 - RPL8P4	22871	402150		19968	65954	rs13074924-?	rs13074924	0	13074924	intergenic_variant	1	0.36	9E-6	5.045757490560675		1.18	[NR]	Illumina [471747]	N
2010-06-21	20516156	Lewis CM	2010-06-01	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20516156	Genome-wide association study of major recurrent depression in the U.K. population.	Major depressive disorder	1,636 European ancestry cases, 1,594 European ancestry controls	1,418 European ancestry cases, 1,918 European ancestry controls	6q27	6	164479565	LOC728275	LOC107986667			107986667			rs4709845-?	rs4709845	0	4709845	intergenic_variant	0	0.85	9E-6	5.045757490560675		1.21	[NR]	Illumina [471747]	N
2014-08-08	24047446	Schosser A	2013-09-19	World J Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/24047446	Genome-wide association study of co-occurring anxiety in major depression.	Anxiety in major depressive disorder	1,080 European ancestry cases, 442 European ancestry controls	NA	1p33	1	47553550	RPL21P24	ATP6V0E1P4 - LOC107984953	100874504	107984953		2800	134948	rs17420782-G	rs17420782	0	17420782	downstream_gene_variant	1	0.16	9E-6	5.045757490560675	(Quantitative)	0.55	[NR] unit increase	Illumina [471581]	N
2014-08-08	24047446	Schosser A	2013-09-19	World J Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/24047446	Genome-wide association study of co-occurring anxiety in major depression.	Anxiety in major depressive disorder	1,080 European ancestry cases, 442 European ancestry controls	NA	11q14.3	11	89733564	LOC100130203	LOC100130203			100130203			rs17221829-A	rs17221829	0	17221829	non_coding_transcript_exon_variant	0	0.38	5E-6	5.301029995663981	(Quantitative)	0.4408	[NR] unit decrease	Illumina [471581]	N
2014-08-08	24047446	Schosser A	2013-09-19	World J Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/24047446	Genome-wide association study of co-occurring anxiety in major depression.	Anxiety in major depressive disorder	1,080 European ancestry cases, 442 European ancestry controls	NA	Xp21.1	X	32195845	DMD	DMD			1756			rs921896-C	rs921896	0	921896	intron_variant	0	0.47	4E-6	5.3979400086720375	(Quantitative)	0.47	[NR] unit increase	Illumina [471581]	N
2014-08-08	24047446	Schosser A	2013-09-19	World J Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/24047446	Genome-wide association study of co-occurring anxiety in major depression.	Anxiety in major depressive disorder	1,080 European ancestry cases, 442 European ancestry controls	NA	3q22.3	3	137049168	IL20RB	IL20RB - RNA5SP142	53833	100873409		38083	468966	rs17374749-?	rs17374749	0	17374749	intergenic_variant	1	0.78	7E-6	5.154901959985743	(Dichotomous)	1.54	[NR]	Illumina [471581]	N
2014-08-08	24047446	Schosser A	2013-09-19	World J Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/24047446	Genome-wide association study of co-occurring anxiety in major depression.	Anxiety in major depressive disorder	1,080 European ancestry cases, 442 European ancestry controls	NA	6q26	6	161254459	AGPAT4	AGPAT4			56895			rs3798943-?	rs3798943	0	3798943	intron_variant	0	0.53	8E-6	5.096910013008056	(Dichotomous)	1.45	[NR]	Illumina [471581]	N
2014-08-08	24047446	Schosser A	2013-09-19	World J Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/24047446	Genome-wide association study of co-occurring anxiety in major depression.	Anxiety in major depressive disorder	1,080 European ancestry cases, 442 European ancestry controls	NA	7p15.1	7	28772876	CREB5	CREB5			9586			rs10238623-A	rs10238623	0	10238623	intron_variant	0	0.28	5E-6	5.301029995663981	(Dichotomous)	1.545	[NR]	Illumina [471581]	N
2014-08-08	24047446	Schosser A	2013-09-19	World J Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/24047446	Genome-wide association study of co-occurring anxiety in major depression.	Anxiety in major depressive disorder	1,080 European ancestry cases, 442 European ancestry controls	NA	9q22.32	9	96065532	LOC158435	ERCC6L2 - LOC158435	375748	158435		24440	307	rs7867155-?	rs7867155	0	7867155	intergenic_variant	1	0.88	9E-7	6.045757490560675	(Dichotomous)	1.84	[NR]	Illumina [471581]	N
2014-08-08	24047446	Schosser A	2013-09-19	World J Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/24047446	Genome-wide association study of co-occurring anxiety in major depression.	Anxiety in major depressive disorder	1,080 European ancestry cases, 442 European ancestry controls	NA	21q22.2	21	40514656	DSCAM	DSCAM			1826			rs9980603-?	rs9980603	0	9980603	intron_variant	0	0.58	3E-7	6.522878745280337	(Dichotomous)	1.53	[NR]	Illumina [471581]	N
2014-10-22	24528284	Ji Y	2014-08-01	Br J Clin Pharmacol	www.ncbi.nlm.nih.gov/pubmed/24528284	Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	300 European ancestry Escitalpram treated individuals, 130 European ancestry Citalopram treated individuals	NA	5p13.3	5	31766326	PDZD2	PDZD2			23037			rs2059865-?	rs2059865	0	2059865	intron_variant	0	0.235	3E-7	6.522878745280337	(S-DCT concentration)			Illumina [7537437] (imputed)	N
2014-08-08	24047446	Schosser A	2013-09-19	World J Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/24047446	Genome-wide association study of co-occurring anxiety in major depression.	Anxiety and major depressive disorder	1,080 European ancestry cases, 1,588 European ancestry controls	NA	6p24.1	6	11811081	C6orf105	LOC107986568 - AMD1P4	107986568	100129761		18	50345	rs3950186-T	rs3950186	0	3950186	non_coding_transcript_exon_variant	1	0.338	8E-6	5.096910013008056		1.319	[NR]	Illumina [471581]	N
2014-08-08	24047446	Schosser A	2013-09-19	World J Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/24047446	Genome-wide association study of co-occurring anxiety in major depression.	Anxiety and major depressive disorder	1,080 European ancestry cases, 1,588 European ancestry controls	NA	9p23	9	10192290	PTPRD	PTPRD			5789			rs294856-?	rs294856	0	294856	intron_variant	0	0.58	2E-6	5.698970004336019		1.34	[NR]	Illumina [471581]	N
2014-08-08	24047446	Schosser A	2013-09-19	World J Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/24047446	Genome-wide association study of co-occurring anxiety in major depression.	Anxiety and major depressive disorder	1,080 European ancestry cases, 1,588 European ancestry controls	NA	17q25.3	17	78637883	CYTH1	LOC101928710 - CYTH1	101928710	9267		5826	36164	rs4796827-A	rs4796827	0	4796827	intergenic_variant	1	0.409	2E-6	5.698970004336019		1.326	[NR]	Illumina [471581]	N
2016-06-08	26079190	Galfalvy H	2015-06-16	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/26079190	A genome-wide association study of suicidal behavior.	Suicide attempts in major depressive disorder	257 European ancestry cases, 300 European ancestry controls	NA	2q14.1	2	115733670	DPP10	DPP10			57628			rs4308128-A	rs4308128	0	4308128	intron_variant	0	0.43	4E-6	5.3979400086720375		1.795	[1.401-2.300]	Illumina [794207]	N
2016-06-08	26079190	Galfalvy H	2015-06-16	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/26079190	A genome-wide association study of suicidal behavior.	Suicide ideation score in major depressive disorder	358 European ancestry individuals	NA	20p12.3	20	8233139	PLCB1	PLCB1			23236			rs6055685-A	rs6055685	0	6055685	intron_variant	0	0.18	8E-7	6.096910013008056		3.568	Suicidal ideation score increase	Illumina [794207]	N
2016-06-08	26079190	Galfalvy H	2015-06-16	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/26079190	A genome-wide association study of suicidal behavior.	Suicide ideation score in major depressive disorder	358 European ancestry individuals	NA	1q31.1	1	190088550	BRINP3, FAM5C	LOC647132 - BRINP3	647132	339479		95347	9112	rs2419374-A	rs2419374	0	2419374	intergenic_variant	1	0.19	1E-6	6.0		3.456	Suicidal ideation score increase	Illumina [794207]	N
2016-06-08	26079190	Galfalvy H	2015-06-16	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/26079190	A genome-wide association study of suicidal behavior.	Suicide ideation score in major depressive disorder	358 European ancestry individuals	NA	5q22.2	5	112267016	EPB41L4A	EPB41L4A			64097			rs13358904-G	rs13358904	0	13358904	intron_variant	0	0.21	5E-6	5.301029995663981		3.049	Suicidal ideation score increase	Illumina [794207]	N
2017-03-17	27089181	Okbay A	2016-04-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27089181	Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.	Depression	105,739 European ancestry individuals, 16,471 European ancestry major depressive disorder cases, 58,835 European ancestry controls	368,890 European ancestry individuals	6p22.1	6	28329086	NR	ZSCAN31			64288			rs853679-A	rs853679	0	853679	intron_variant	0	NR	1E-7	7.0		5.298256	[NR] z score decrease	Affymetrix [up to 6544862] (imputed)	N
2017-03-17	27089181	Okbay A	2016-04-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27089181	Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.	Depression	105,739 European ancestry individuals, 16,471 European ancestry major depressive disorder cases, 58,835 European ancestry controls	368,890 European ancestry individuals	18q21.2	18	53228263	DCC	DCC			1630			rs62100776-A	rs62100776	0	62100776	intron_variant	0	NR	1E-8	8.0		5.6640935	[NR] z score decrease	Affymetrix [up to 6544862] (imputed)	N
2017-03-17	27089181	Okbay A	2016-04-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27089181	Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.	Depression	105,739 European ancestry individuals, 16,471 European ancestry major depressive disorder cases, 58,835 European ancestry controls	368,890 European ancestry individuals	11q23.3	11	118444134	NR	KMT2A			4297			rs2017122-T	rs2017122	0	2017122	intron_variant	0	NR	1E-6	6.0		4.811745	[NR] z score increase	Affymetrix [up to 6544862] (imputed)	N
2017-03-17	27089181	Okbay A	2016-04-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27089181	Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.	Depression	105,739 European ancestry individuals, 16,471 European ancestry major depressive disorder cases, 58,835 European ancestry controls	368,890 European ancestry individuals	4q31.1	4	140004716	NR	MAML3			55534			rs1877075-A	rs1877075	0	1877075	intron_variant	0	NR	2E-6	5.698970004336019		4.810405	[NR] z score decrease	Affymetrix [up to 6544862] (imputed)	N
2017-03-17	27089181	Okbay A	2016-04-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27089181	Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.	Depression	105,739 European ancestry individuals, 16,471 European ancestry major depressive disorder cases, 58,835 European ancestry controls	368,890 European ancestry individuals	10q25.1	10	104940636	NR	SORCS3			22986			rs7074335-T	rs7074335	0	7074335	intron_variant	0	NR	2E-6	5.698970004336019		4.758858	[NR] z score increase	Affymetrix [up to 6544862] (imputed)	N
2017-03-17	27089181	Okbay A	2016-04-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27089181	Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.	Depression	105,739 European ancestry individuals, 16,471 European ancestry major depressive disorder cases, 58,835 European ancestry controls	368,890 European ancestry individuals	12q24.23	12	117937681	KSR2	KSR2			283455			rs7973260-A	rs7973260	0	7973260	intron_variant	0	NR	2E-8	7.698970004336019		5.6011147	[NR] z score increase	Affymetrix [up to 6544862] (imputed)	N
2017-03-17	27089181	Okbay A	2016-04-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27089181	Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.	Depression	105,739 European ancestry individuals, 16,471 European ancestry major depressive disorder cases, 58,835 European ancestry controls	368,890 European ancestry individuals	4q32.1	4	158858089	NR	FNIP2			57600			rs6828666-A	rs6828666	0	6828666	intron_variant	0	NR	3E-6	5.522878745280337		4.6532216	[NR] z score decrease	Affymetrix [up to 6544862] (imputed)	N
2017-03-17	27089181	Okbay A	2016-04-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27089181	Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.	Depression	105,739 European ancestry individuals, 16,471 European ancestry major depressive disorder cases, 58,835 European ancestry controls	368,890 European ancestry individuals	20q13.13	20	48918761	NR	LOC105372648 - ARFGEF2	105372648	10564		30588	2960	rs4810896-A	rs4810896	0	4810896	upstream_gene_variant	1	NR	4E-9	8.397940008672037		5.8794484	[NR] z score decrease	Affymetrix [up to 6544862] (imputed)	N
2017-03-17	27089181	Okbay A	2016-04-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27089181	Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.	Depression	105,739 European ancestry individuals, 16,471 European ancestry major depressive disorder cases, 58,835 European ancestry controls	368,890 European ancestry individuals	15q14	15	38627763	NR	LOC107984725 - LOC105370775	107984725	105370775		7320	44006	rs59659806-T	rs59659806	0	59659806	intergenic_variant	1	NR	5E-6	5.301029995663981		4.563033	[NR] z score decrease	Affymetrix [up to 6544862] (imputed)	N
2017-03-17	27089181	Okbay A	2016-04-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27089181	Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.	Depression	105,739 European ancestry individuals, 16,471 European ancestry major depressive disorder cases, 58,835 European ancestry controls	368,890 European ancestry individuals	10q25.1	10	105701367	NR	LOC101927549			101927549			rs10884216-T	rs10884216	0	10884216	intergenic_variant	0	NR	6E-7	6.221848749616356		4.994715	[NR] z score decrease	Affymetrix [up to 6544862] (imputed)	N
2017-03-17	27089181	Okbay A	2016-04-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27089181	Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.	Depression	105,739 European ancestry individuals, 16,471 European ancestry major depressive disorder cases, 58,835 European ancestry controls	368,890 European ancestry individuals	9p23	9	11557797	NR	LOC105375974 - LOC105375975	105375974	105375975		55199	52425	rs10809520-T	rs10809520	0	10809520	intergenic_variant	1	NR	6E-9	8.221848749616356		5.8197784	[NR] z score decrease	Affymetrix [up to 6544862] (imputed)	N
2017-03-17	27089181	Okbay A	2016-04-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27089181	Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.	Depression	105,739 European ancestry individuals, 16,471 European ancestry major depressive disorder cases, 58,835 European ancestry controls	368,890 European ancestry individuals	11q22.1	11	99625823	NR	CNTN5			53942			rs1690818-T	rs1690818	0	1690818	intron_variant	0	NR	6E-8	7.221848749616356		5.4051075	[NR] z score decrease	Affymetrix [up to 6544862] (imputed)	N
2017-03-17	27089181	Okbay A	2016-04-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27089181	Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.	Depression	105,739 European ancestry individuals, 16,471 European ancestry major depressive disorder cases, 58,835 European ancestry controls	368,890 European ancestry individuals	12q23.2	12	103218955	NR	C12orf42			374470			rs1961982-A	rs1961982	0	1961982	intergenic_variant	0	NR	7E-7	6.154901959985743		4.971417	[NR] z score decrease	Affymetrix [up to 6544862] (imputed)	N
2017-03-17	27089181	Okbay A	2016-04-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27089181	Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.	Depression	105,739 European ancestry individuals, 16,471 European ancestry major depressive disorder cases, 58,835 European ancestry controls	368,890 European ancestry individuals	1p31.1	1	72479983	NR	LOC105378797			105378797			rs782212-T	rs782212	0	782212	regulatory_region_variant	0	NR	7E-11	10.154901959985743		6.516477	[NR] z score decrease	Affymetrix [up to 6544862] (imputed)	N
2017-03-17	27089181	Okbay A	2016-04-18	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27089181	Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.	Depression	105,739 European ancestry individuals, 16,471 European ancestry major depressive disorder cases, 58,835 European ancestry controls	368,890 European ancestry individuals	7q31.31	7	117883655	NR	CTTNBP2 - LOC105375470	83992	105375470		10148	267694	rs10233018-A	rs10233018	0	10233018	non_coding_transcript_exon_variant	1	NR	9E-8	7.045757490560675		5.3463354	[NR] z score decrease	Affymetrix [up to 6544862] (imputed)	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	3p21.31	3	45689959	SACM1L	SACM1L			22908			rs2742417-T	rs2742417	0	2742417	5_prime_UTR_variant	0	0.49	5E-7	6.301029995663981	(Bupropion, Sexual side effects)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	12q22	12	95566012	USP44	USP44 - PGAM1P5	84101	100132594		14483	83243	rs7136572-G	rs7136572	0	7136572	intron_variant	1	0.04	3E-7	6.522878745280337	(Bupropion, Sexual side effects)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	2p14	2	67746755	intergenic	LOC105374786 - LOC101927701	105374786	101927701		95725	49299	rs13432159-G	rs13432159	0	13432159	intergenic_variant	1	0.08	9E-8	7.045757490560675	(Sertraline, General side effects)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	10q11.23	10	48777065	WDFY4	WDFY4			57705			rs10857636-T	rs10857636	0	10857636	intron_variant	0	0.06	2E-7	6.698970004336019	(Bupropion, General side effects)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	7q21.11	7	78413974	MAGI2	MAGI2			9863			rs17150687-C	rs17150687	0	17150687	intron_variant	0	0.02	3E-6	5.522878745280337	(Bupropion, Sexual side effects)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	2p14	2	67749656	intergenic	LOC105374786 - LOC101927701	105374786	101927701		98626	46398	rs6724422-T	rs6724422	0	6724422	intergenic_variant	1	0.06	4E-7	6.3979400086720375	(Sertraline, General side effects)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	5p14.1	5	28340066	intergenic	LOC105374698 - LOC105374701	105374698	105374701		52401	208309	rs11949289-T	rs11949289	0	11949289	intergenic_variant	1	0.42	2E-7	6.698970004336019	(Venlafaxine, Dizziness)			Affymetrix [421789]	N
2015-05-27	21339755	Liu X	2011-02-22	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/21339755	A non-synonymous polymorphism in galactose mutarotase (GALM) is associated with serotonin transporter binding potential in the human thalamus: results of a genome-wide association study.	5-HTT brain serotonin transporter levels	16 European, African American and Hispanic unmedicated bipolar disorder cases, 17 European, African American and Hispanic unmedicated major depressive disorder cases, 22 controls	51 European ancestry individuals	2p22.1	2	38689828	GALM	GALM			130589			rs6741892-?	rs6741892	0	6741892	missense_variant	0	NR	5E-6	5.301029995663981	(thalamus)			Illumina [93247]	N
2009-11-25	19846067	Garriock HA	2009-10-19	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/19846067	A genomewide association study of citalopram response in major depressive disorder.	Response to citalopram treatment	Up to 659 European ancestry responders, up to 121 African American responders, up to 103 Hispanic responders, 408 European ancestry non-responders, 120 African American non-responders, 80 Hispanic non-responders	NA	7q36.3	7	157087704	UBE3C	MNX1-AS1 - LOC645272	645249	645272		71280	404	rs6966038-?	rs6966038	0	6966038	downstream_gene_variant	1	0.19	5E-7	6.301029995663981	(response)	1.64	[1.35-1.99]	Affymetrix [430198]	N
2009-11-25	19846067	Garriock HA	2009-10-19	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/19846067	A genomewide association study of citalopram response in major depressive disorder.	Response to citalopram treatment	Up to 659 European ancestry responders, up to 121 African American responders, up to 103 Hispanic responders, 408 European ancestry non-responders, 120 African American non-responders, 80 Hispanic non-responders	NA	20q13.31	20	57063694	BMP7	LOC105372683 - LOC105372685	105372683	105372685		77492	53495	rs6127921-?	rs6127921	0	6127921	intergenic_variant	1	0.82	3E-6	5.522878745280337	(response)	1.64	[1.33-2.04]	Affymetrix [430198]	N
2009-11-25	19846067	Garriock HA	2009-10-19	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/19846067	A genomewide association study of citalopram response in major depressive disorder.	Response to citalopram treatment	Up to 659 European ancestry responders, up to 121 African American responders, up to 103 Hispanic responders, 408 European ancestry non-responders, 120 African American non-responders, 80 Hispanic non-responders	NA	15q22.2	15	61037589	RORA	RORA, LOC107984805			6095, 107984805			rs809736-?	rs809736	0	809736	intron_variant	0	0.17	8E-6	5.096910013008056	(response)	1.52	[1.27-1.83]	Affymetrix [430198]	N
2009-11-25	19846067	Garriock HA	2009-10-19	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/19846067	A genomewide association study of citalopram response in major depressive disorder.	Response to citalopram treatment	Up to 659 European ancestry responders, up to 121 African American responders, up to 103 Hispanic responders, 408 European ancestry non-responders, 120 African American non-responders, 80 Hispanic non-responders	NA	7q36.3	7	157087704	UBE3C	MNX1-AS1 - LOC645272	645249	645272		71280	404	rs6966038-?	rs6966038	0	6966038	downstream_gene_variant	1	0.20	4E-7	6.3979400086720375	(remission)	1.68	[1.37-2.04]	Affymetrix [430198]	N
2009-11-25	19846067	Garriock HA	2009-10-19	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/19846067	A genomewide association study of citalopram response in major depressive disorder.	Response to citalopram treatment	Up to 659 European ancestry responders, up to 121 African American responders, up to 103 Hispanic responders, 408 European ancestry non-responders, 120 African American non-responders, 80 Hispanic non-responders	NA	20q13.31	20	57063694	BMP7	LOC105372683 - LOC105372685	105372683	105372685		77492	53495	rs6127921-?	rs6127921	0	6127921	intergenic_variant	1	0.81	1E-6	6.0	(remission)	1.75	[1.39-2.17]	Affymetrix [430198]	N
2009-11-25	19846067	Garriock HA	2009-10-19	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/19846067	A genomewide association study of citalopram response in major depressive disorder.	Response to citalopram treatment	Up to 659 European ancestry responders, up to 121 African American responders, up to 103 Hispanic responders, 408 European ancestry non-responders, 120 African American non-responders, 80 Hispanic non-responders	NA	21q21.3	21	27293028	EIF4A1P	LOC102724355			102724355			rs2830840-?	rs2830840	0	2830840	intergenic_variant	0	0.46	5E-6	5.301029995663981	(remission)	1.47	[1.23-1.72]	Affymetrix [430198]	N
2009-11-25	19846067	Garriock HA	2009-10-19	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/19846067	A genomewide association study of citalopram response in major depressive disorder.	Response to citalopram treatment	Up to 659 European ancestry responders, up to 121 African American responders, up to 103 Hispanic responders, 408 European ancestry non-responders, 120 African American non-responders, 80 Hispanic non-responders	NA	18q12.1	18	34065415	NOL4	NOL4			8715			rs7239368-?	rs7239368	0	7239368	intron_variant	0	0.42	9E-6	5.045757490560675	(remission)	1.45	[1.22-1.69]	Affymetrix [430198]	N
2016-07-06	25993607	de Moor MH	2015-05-20	JAMA Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25993607	Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder.	Neuroticism	Up to 627 Cilento (founder/genetic isolate) individuals, up to 2,296 Erasmus Rupchen (founder/genetic isolate) individuals, up to 1,650 Orcadian (founder/genetic isolate) individuals, up to 909 Vis (founder/genetic isolate) individuals, up to 58,179 European ancestry individuals	Up to 9,786 European ancestry individuals	3p14.1	3	65557181	MAGI1	MAGI1			9223			rs35855737-C	rs35855737	0	35855737	intron_variant	0	0.18	2E-8	7.698970004336019		0.04	[NR] unit decrease	Affymetrix, Illumina, Perlegen [6949614] (imputed)	N
2016-07-06	25993607	de Moor MH	2015-05-20	JAMA Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25993607	Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder.	Neuroticism	Up to 627 Cilento (founder/genetic isolate) individuals, up to 2,296 Erasmus Rupchen (founder/genetic isolate) individuals, up to 1,650 Orcadian (founder/genetic isolate) individuals, up to 909 Vis (founder/genetic isolate) individuals, up to 58,179 European ancestry individuals	Up to 9,786 European ancestry individuals	3q13.32	3	118382879	NR	LOC107986022 - LOC105374058	107986022	105374058		385259	105921	rs10934447-A	rs10934447	0	10934447	intron_variant	1	NR	4E-6	5.3979400086720375		0.035	[0.021-0.049] unit increase	Affymetrix, Illumina, Perlegen [6949614] (imputed)	N
2016-07-06	25993607	de Moor MH	2015-05-20	JAMA Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25993607	Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder.	Neuroticism	Up to 627 Cilento (founder/genetic isolate) individuals, up to 2,296 Erasmus Rupchen (founder/genetic isolate) individuals, up to 1,650 Orcadian (founder/genetic isolate) individuals, up to 909 Vis (founder/genetic isolate) individuals, up to 58,179 European ancestry individuals	Up to 9,786 European ancestry individuals	5p12	5	45849627	NR	HCN1 - EMB	348980	133418		153509	4546565	rs10941710-A	rs10941710	0	10941710	intergenic_variant	1	NR	8E-6	5.096910013008056		0.032	[0.018-0.046] unit decrease	Affymetrix, Illumina, Perlegen [6949614] (imputed)	N
2016-07-06	25993607	de Moor MH	2015-05-20	JAMA Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25993607	Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder.	Neuroticism	Up to 627 Cilento (founder/genetic isolate) individuals, up to 2,296 Erasmus Rupchen (founder/genetic isolate) individuals, up to 1,650 Orcadian (founder/genetic isolate) individuals, up to 909 Vis (founder/genetic isolate) individuals, up to 58,179 European ancestry individuals	Up to 9,786 European ancestry individuals	5q34	5	165038884	NR	LOC105377703			105377703			rs56118546-T	rs56118546	0	56118546	intron_variant	0	NR	1E-6	6.0		0.039	[0.023-0.055] unit decrease	Affymetrix, Illumina, Perlegen [6949614] (imputed)	N
2016-07-06	25993607	de Moor MH	2015-05-20	JAMA Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25993607	Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder.	Neuroticism	Up to 627 Cilento (founder/genetic isolate) individuals, up to 2,296 Erasmus Rupchen (founder/genetic isolate) individuals, up to 1,650 Orcadian (founder/genetic isolate) individuals, up to 909 Vis (founder/genetic isolate) individuals, up to 58,179 European ancestry individuals	Up to 9,786 European ancestry individuals	5q34	5	165149962	NR	LOC105377702			105377702			rs72817562-T	rs72817562	0	72817562	intron_variant	0	NR	2E-6	5.698970004336019		0.035	[0.019-0.051] unit increase	Affymetrix, Illumina, Perlegen [6949614] (imputed)	N
2016-07-06	25993607	de Moor MH	2015-05-20	JAMA Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25993607	Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder.	Neuroticism	Up to 627 Cilento (founder/genetic isolate) individuals, up to 2,296 Erasmus Rupchen (founder/genetic isolate) individuals, up to 1,650 Orcadian (founder/genetic isolate) individuals, up to 909 Vis (founder/genetic isolate) individuals, up to 58,179 European ancestry individuals	Up to 9,786 European ancestry individuals	6p22.2	6	27089300	NR	VN1R11P - TRP-CGG2-1	387317	100189172		5084	2442	rs2393911-T	rs2393911	0	2393911	intergenic_variant	1	NR	5E-7	6.301029995663981		0.039	[0.023-0.055] unit decrease	Affymetrix, Illumina, Perlegen [6949614] (imputed)	N
2016-07-06	25993607	de Moor MH	2015-05-20	JAMA Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25993607	Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder.	Neuroticism	Up to 627 Cilento (founder/genetic isolate) individuals, up to 2,296 Erasmus Rupchen (founder/genetic isolate) individuals, up to 1,650 Orcadian (founder/genetic isolate) individuals, up to 909 Vis (founder/genetic isolate) individuals, up to 58,179 European ancestry individuals	Up to 9,786 European ancestry individuals	7q34	7	142887261	NR	TRPV6 - TRPV5	55503	56302		1516	20840	rs4987595-T	rs4987595	0	4987595	intron_variant	1	NR	1E-6	6.0		0.044	[0.024-0.064] unit decrease	Affymetrix, Illumina, Perlegen [6949614] (imputed)	N
2016-07-06	25993607	de Moor MH	2015-05-20	JAMA Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25993607	Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder.	Neuroticism	Up to 627 Cilento (founder/genetic isolate) individuals, up to 2,296 Erasmus Rupchen (founder/genetic isolate) individuals, up to 1,650 Orcadian (founder/genetic isolate) individuals, up to 909 Vis (founder/genetic isolate) individuals, up to 58,179 European ancestry individuals	Up to 9,786 European ancestry individuals	8p11.22	8	38923522	NR	PLEKHA2			59339			rs11782824-A	rs11782824	0	11782824	intron_variant	0	NR	4E-6	5.3979400086720375		0.027	[0.015-0.039] unit decrease	Affymetrix, Illumina, Perlegen [6949614] (imputed)	N
2016-07-06	25993607	de Moor MH	2015-05-20	JAMA Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25993607	Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder.	Neuroticism	Up to 627 Cilento (founder/genetic isolate) individuals, up to 2,296 Erasmus Rupchen (founder/genetic isolate) individuals, up to 1,650 Orcadian (founder/genetic isolate) individuals, up to 909 Vis (founder/genetic isolate) individuals, up to 58,179 European ancestry individuals	Up to 9,786 European ancestry individuals	9p23	9	10881231	NR	IMP3P1 - AKAP8P1	646087	646114		50923	130513	rs113399772-A	rs113399772	0	113399772	intergenic_variant	1	NR	2E-6	5.698970004336019		0.061	[0.034-0.088] unit increase	Affymetrix, Illumina, Perlegen [6949614] (imputed)	N
2016-07-06	25993607	de Moor MH	2015-05-20	JAMA Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25993607	Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder.	Neuroticism	Up to 627 Cilento (founder/genetic isolate) individuals, up to 2,296 Erasmus Rupchen (founder/genetic isolate) individuals, up to 1,650 Orcadian (founder/genetic isolate) individuals, up to 909 Vis (founder/genetic isolate) individuals, up to 58,179 European ancestry individuals	Up to 9,786 European ancestry individuals	11p12	11	42204277	NR	LOC100507205			100507205			rs77124415-C	rs77124415	0	77124415	intron_variant	0	NR	5E-6	5.301029995663981		0.059	[0.034-0.084] unit increase	Affymetrix, Illumina, Perlegen [6949614] (imputed)	N
2016-07-06	25993607	de Moor MH	2015-05-20	JAMA Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25993607	Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder.	Neuroticism	Up to 627 Cilento (founder/genetic isolate) individuals, up to 2,296 Erasmus Rupchen (founder/genetic isolate) individuals, up to 1,650 Orcadian (founder/genetic isolate) individuals, up to 909 Vis (founder/genetic isolate) individuals, up to 58,179 European ancestry individuals	Up to 9,786 European ancestry individuals	20p12.1	20	12708954	NR	LOC105372532 - LOC101929486	105372532	101929486		35751	156250	rs35548558-T	rs35548558	0	35548558	intergenic_variant	1	NR	4E-6	5.3979400086720375		0.027	[0.015-0.039] unit increase	Affymetrix, Illumina, Perlegen [6949614] (imputed)	N
2016-07-06	25993607	de Moor MH	2015-05-20	JAMA Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25993607	Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder.	Neuroticism	Up to 627 Cilento (founder/genetic isolate) individuals, up to 2,296 Erasmus Rupchen (founder/genetic isolate) individuals, up to 1,650 Orcadian (founder/genetic isolate) individuals, up to 909 Vis (founder/genetic isolate) individuals, up to 58,179 European ancestry individuals	Up to 9,786 European ancestry individuals	22q12.3	22	33786902	NR	LARGE			9215			rs1811103-A	rs1811103	0	1811103	intron_variant	0	NR	8E-6	5.096910013008056		0.039	[0.023-0.055] unit increase	Affymetrix, Illumina, Perlegen [6949614] (imputed)	N
2014-10-22	24528284	Ji Y	2014-08-01	Br J Clin Pharmacol	www.ncbi.nlm.nih.gov/pubmed/24528284	Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	300 European ancestry Escitalpram treated individuals, 130 European ancestry Citalopram treated individuals	NA	17q25.3	17	79831041	CBX4	LOC105371919 - CBX4	105371919	8535		3337	2115	rs9747992-?	rs9747992	0	9747992	downstream_gene_variant	1	0.086	2E-7	6.698970004336019	(S-DCT concentration)			Illumina [7537437] (imputed)	N
2014-10-22	24528284	Ji Y	2014-08-01	Br J Clin Pharmacol	www.ncbi.nlm.nih.gov/pubmed/24528284	Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	300 European ancestry Escitalpram treated individuals, 130 European ancestry Citalopram treated individuals	NA	11p15.3	11	13107616	CTC-497E21.5	RASSF10 - LOC105376558	644943	105376558		95510	3887	rs117020818-?	rs117020818	0	117020818	intron_variant	1	0.046	7E-7	6.154901959985743	(S-DCT concentration)			Illumina [7537437] (imputed)	N
2014-10-22	24528284	Ji Y	2014-08-01	Br J Clin Pharmacol	www.ncbi.nlm.nih.gov/pubmed/24528284	Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	300 European ancestry Escitalpram treated individuals, 130 European ancestry Citalopram treated individuals	NA	10q23.33	10	94922089	CYP2C9, CYP2C19	CYP2C9			1559			rs1074145-?	rs1074145	0	1074145	intergenic_variant	0	0.162	4E-9	8.397940008672037	(S-CT concentration)			Illumina [7537437] (imputed)	N
2014-10-22	24528284	Ji Y	2014-08-01	Br J Clin Pharmacol	www.ncbi.nlm.nih.gov/pubmed/24528284	Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	300 European ancestry Escitalpram treated individuals, 130 European ancestry Citalopram treated individuals	NA	10q23.33	10	94922089	CYP2C9, CYP2C19	CYP2C9			1559			rs1074145-?	rs1074145	0	1074145	intergenic_variant	0	0.162	2E-16	15.698970004336019	(S-DCT/S-CT ratio)			Illumina [7537437] (imputed)	N
2014-10-22	24528284	Ji Y	2014-08-01	Br J Clin Pharmacol	www.ncbi.nlm.nih.gov/pubmed/24528284	Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	300 European ancestry Escitalpram treated individuals, 130 European ancestry Citalopram treated individuals	NA	20q12	20	39943772	HSPEP1	HSPE1P1 - LINC01370	140895	100505663		10533	60689	rs55734731-?	rs55734731	0	55734731	intergenic_variant	1	0.124	4E-7	6.3979400086720375	(S-CT concentration, adjusted for CYP2C19)			Illumina [7537437] (imputed)	N
2014-10-22	24528284	Ji Y	2014-08-01	Br J Clin Pharmacol	www.ncbi.nlm.nih.gov/pubmed/24528284	Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	300 European ancestry Escitalpram treated individuals, 130 European ancestry Citalopram treated individuals	NA	7q22.1	7	101642897	MYL10	MYL10 - CUX1	93408	1523		13601	173007	rs1722229-?	rs1722229	0	1722229	intergenic_variant	1	0.034	1E-6	6.0	(S-CT concentration, adjusted for CYP2C19)			Illumina [7537437] (imputed)	N
2014-10-22	24528284	Ji Y	2014-08-01	Br J Clin Pharmacol	www.ncbi.nlm.nih.gov/pubmed/24528284	Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	300 European ancestry Escitalpram treated individuals, 130 European ancestry Citalopram treated individuals	NA	4q35.2	4	188269957	TRIML1	LOC105377607 - RPL7AP27	105377607	152663		87005	79361	rs71607999-?	rs71607999	0	71607999	intergenic_variant	1	0.165	7E-9	8.154901959985743	(S-DCT/S-CT ratio, adjusted for CYP2C19)			Illumina [7537437] (imputed)	N
2014-10-22	24528284	Ji Y	2014-08-01	Br J Clin Pharmacol	www.ncbi.nlm.nih.gov/pubmed/24528284	Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	300 European ancestry Escitalpram treated individuals, 130 European ancestry Citalopram treated individuals	NA	4p15.1	4	27962783	AC007106.1	LOC105374552			105374552			rs11934750-?	rs11934750	0	11934750	downstream_gene_variant	0	0.160	1E-7	7.0	(S-DCT/S-CT ratio, adjusted for CYP2C19)			Illumina [7537437] (imputed)	N
2014-10-22	24528284	Ji Y	2014-08-01	Br J Clin Pharmacol	www.ncbi.nlm.nih.gov/pubmed/24528284	Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	300 European ancestry Escitalpram treated individuals, 130 European ancestry Citalopram treated individuals	NA	12q23.3	12	104360722	EID3	TXNRD1 - LOC105369949	7296	105369949		10415	16353	rs77724872-?	rs77724872	0	77724872	intergenic_variant	1	0.047	7E-7	6.154901959985743	(S-DCT concentration, adjusted for CYP2C19)			Illumina [7537437] (imputed)	N
2014-10-22	24528284	Ji Y	2014-08-01	Br J Clin Pharmacol	www.ncbi.nlm.nih.gov/pubmed/24528284	Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	300 European ancestry Escitalpram treated individuals, 130 European ancestry Citalopram treated individuals	NA	19q13.33	19	49727070	CTB-33G10.1	RPS9P4 - TSKS	388556	60385		6933	12683	rs8102150-?	rs8102150	0	8102150	intergenic_variant	1	0.028	7E-7	6.154901959985743	(S-DCT concentration, adjusted for CYP2C19)			Illumina [7537437] (imputed)	N
2014-10-22	24528284	Ji Y	2014-08-01	Br J Clin Pharmacol	www.ncbi.nlm.nih.gov/pubmed/24528284	Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	300 European ancestry Escitalpram treated individuals, 130 European ancestry Citalopram treated individuals	NA	22q13.2	22	41996807	SEPT, LOC100132273, LOC388906, CYP2D6	LOC102723706, SEPT3			102723706, 55964			rs1058172-?	rs1062753	0	1062753	3_prime_UTR_variant	0	0.155	2E-16	15.698970004336019	(S-DDCT concentration)			Illumina [7537437] (imputed)	N
2014-10-22	24528284	Ji Y	2014-08-01	Br J Clin Pharmacol	www.ncbi.nlm.nih.gov/pubmed/24528284	Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	300 European ancestry Escitalpram treated individuals, 130 European ancestry Citalopram treated individuals	NA	22q13.2	22	42127526	SEPT, LOC100132273, LOC388906, CYP2D6	CYP2D6			1565			rs1058172-?	rs1058172	0	1058172	missense_variant	0	0.155	8E-16	15.096910013008056	(S-DDCT/S-DCT ratio)			Illumina [7537437] (imputed)	N
2014-10-22	24528284	Ji Y	2014-08-01	Br J Clin Pharmacol	www.ncbi.nlm.nih.gov/pubmed/24528284	Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	300 European ancestry Escitalpram treated individuals, 130 European ancestry Citalopram treated individuals	NA	22q13.2	22	42130692	CYP2D6*4, CYP2D6*10, CYP2D6*14	CYP2D6, LOC102723722			1565, 102723722			rs1065852-?	rs1065852	0	1065852	missense_variant	0	0.215	2E-16	15.698970004336019	(S-DDCT concentration)			Illumina [7537437] (imputed)	N
2014-10-22	24528284	Ji Y	2014-08-01	Br J Clin Pharmacol	www.ncbi.nlm.nih.gov/pubmed/24528284	Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	300 European ancestry Escitalpram treated individuals, 130 European ancestry Citalopram treated individuals	NA	22q13.2	22	42130692	CYP2D6*4, CYP2D6*10, CYP2D6*14	CYP2D6, LOC102723722			1565, 102723722			rs1065852-?	rs1065852	0	1065852	missense_variant	0	0.215	8E-16	15.096910013008056	(S-DDCT/S-DCT ratio)			Illumina [7537437] (imputed)	N
2016-11-14	26845276	Ikeda M	2016-01-01	J Clin Psychiatry	www.ncbi.nlm.nih.gov/pubmed/26845276	Genome-wide environment interaction between depressive state and stressful life events.	Major depressive disorder (stressful life events interaction)	308 East Asian ancestry prepressive cases, 780 East Asian ancestry non-depressive controls	NA	7q21.11	7	82414674	CACNA2D1	CACNA2D1			781			rs17156280-C	rs17156280	0	17156280	intron_variant	0	0.142	2E-7	6.698970004336019				Illumina [418225]	N
2016-11-14	26845276	Ikeda M	2016-01-01	J Clin Psychiatry	www.ncbi.nlm.nih.gov/pubmed/26845276	Genome-wide environment interaction between depressive state and stressful life events.	Major depressive disorder (stressful life events interaction)	308 East Asian ancestry prepressive cases, 780 East Asian ancestry non-depressive controls	NA	20p12.3	20	7279278	BMP2	LINC01428 - LOC101929288	101929265	101929288		25076	22811	rs10485715-C	rs10485715	0	10485715	intergenic_variant	1	0.144	8E-9	8.096910013008056				Illumina [418225]	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	5q23.2	5	125363546	LOC644659	LOC101927421			101927421			rs6889896-?	rs6889896	0	6889896	intron_variant	0	NR	5E-7	6.301029995663981	(% Change in score)	0.17	[NR] unit decrease	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	2q24.1	2	157933913	LOC100130766	LOC105373714 - LOC100130766	105373714	100130766		15534	27461	rs35806662-?	rs35806662	0	35806662	intron_variant	1	NR	6E-7	6.221848749616356	(% Change in score)	0.2	[NR] unit decrease	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	5p13.3	5	32278127	MTMR12	MTMR12			54545			rs73069924-?	rs73069924	0	73069924	intron_variant	0	NR	8E-7	6.096910013008056	(% Change in score)	0.44	[NR] unit decrease	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	6p24.1	6	13070841	PHACTR1	PHACTR1			221692			rs4615376-?	rs4615376	0	4615376	intron_variant	0	NR	1E-6	6.0	(% Change in score)	0.16	[NR] unit decrease	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	11p15.4	11	4583965	C11orf40, OR52I2	C11orf40 - OR52I2	143501	143502		6145	2826	rs2566255-?	rs2566255	0	2566255	intron_variant	1	NR	2E-6	5.698970004336019	(% Change in score)	0.26	[NR] unit increase	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	6p22.3	6	17505713	CAP2	LOC101928491, CAP2			101928491, 10486			rs910039-?	rs910039	0	910039	intron_variant	0	NR	2E-6	5.698970004336019	(% Change in score)	0.13	[NR] unit increase	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	6q24.1	6	138928988	REPS1	REPS1			85021			rs17068112-?	rs17068112	0	17068112	3_prime_UTR_variant	0	NR	3E-6	5.522878745280337	(% Change in score)	0.26	[NR] unit increase	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	12q24.33	12	131154308	LOC116437	ADGRD1 - LINC01257	283383	116437		12839	10703	rs7485210-?	rs7485210	0	7485210	intergenic_variant	1	NR	3E-6	5.522878745280337	(% Change in score)	0.14	[NR] unit increase	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	5p13.1	5	38870806	OSMR	OSMR			9180			rs74378198-?	rs74378198	0	74378198	intron_variant	0	NR	4E-6	5.3979400086720375	(% Change in score)	0.43	[NR] unit decrease	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	7p21.3	7	9648479	PER4	LOC105375145			105375145			rs4236420-?	rs4236420	0	4236420	intergenic_variant	0	NR	4E-6	5.3979400086720375	(% Change in score)	0.13	[NR] unit increase	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	11q21	11	93958166	HPRTP4	LOC101060084			101060084			rs2456568-?	rs2456568	0	2456568	intergenic_variant	0	NR	5E-8	7.301029995663981	(Response)	1.36	[NR]	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	8q21.13	8	79644265	STMN2	STMN2			11075			rs113889867-?	rs113889867	0	113889867	intron_variant	0	NR	9E-7	6.045757490560675	(Response)	1.96	[NR]	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	8p12	8	31622107	NRG1	RNA5SP261 - NRG1	100873515	3084		23903	17115	rs10954808-?	rs10954808	0	10954808	intergenic_variant	1	NR	1E-6	6.0	(Response)	1.37	[NR]	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	1p35.1	1	33973693	CSMD2	CSMD2			114784			rs506546-?	rs506546	0	506546	intron_variant	0	NR	1E-6	6.0	(Response)	1.32	[NR]	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	1q32.1	1	205911051	SLC26A9	LOC284581 - SLC26A9	284581	115019		14964	1997	rs74546197-?	rs74546197	0	74546197	downstream_gene_variant	1	NR	3E-6	5.522878745280337	(Response)	2.17	[NR]	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	1q44	1	247853076	TRIM58	OR11L1 - TRIM58	391189	25893		11180	4123	rs72772787-?	rs72772787	0	72772787	upstream_gene_variant	1	NR	4E-6	5.3979400086720375	(Response)	2.34	[NR]	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	9q21.13	9	71336039	TRPM3	TRPM3			80036			rs2043144-?	rs2043144	0	2043144	intron_variant	0	NR	4E-6	5.3979400086720375	(Response)	2.63	[NR]	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	15q26.2	15	95072557	LOC400456	LOC105370991			105370991			rs291028-?	rs291028	0	291028	intron_variant	0	NR	5E-6	5.301029995663981	(Response)	1.64	[NR]	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	Xp22.11	X	23356860	PTCHD1	PTCHD1			139411			rs7051085-?	rs7051085	0	7051085	intron_variant	0	NR	6E-6	5.221848749616356	(Response)	1.59	[NR]	Illumina [~ 7000000] (imputed)	N
2015-12-02	25897834	Biernacka JM	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897834	The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.	Response to serotonin reuptake inhibitors in major depressive disorder	298 European ancestry cases, 567 Asian ancestry cases, 1529 European and other ancestry cases	NA	22q11.21	22	18994050	DGCR5	DGCR5			26220			rs1210638-?	rs1210638	0	1210638	non_coding_transcript_exon_variant	0	NR	6E-6	5.221848749616356	(Response)	1.33	[NR]	Illumina [~ 7000000] (imputed)	N
2017-05-12	28049566	Direk N	2016-12-08	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/28049566	An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype.	Depressive symptom measurement or major depressive disorder	9,240 European ancestry cases, 9,519 European ancestry controls, 51,150 European ancestry individuals with depressive symptom measurement	6,879 European ancestry cases, 13,453 European ancestry controls, 5,303 Chinese ancestry cases, 5,337 Chinese ancestry controls, 8,157 European American individuals with depressive symptom measurement	14q24.1	14	67406411	PLEK2	PLEK2, GPHN			26499, 10243			rs9323497-?	rs9323497	0	9323497	intron_variant	0	NR	4E-6	5.3979400086720375	(European)	4.61	Z score increase	Affymetrix, Illumina, Perlegen [918921] (imputed)	N
2017-05-12	28049566	Direk N	2016-12-08	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/28049566	An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype.	Depressive symptom measurement or major depressive disorder	9,240 European ancestry cases, 9,519 European ancestry controls, 51,150 European ancestry individuals with depressive symptom measurement	6,879 European ancestry cases, 13,453 European ancestry controls, 5,303 Chinese ancestry cases, 5,337 Chinese ancestry controls, 8,157 European American individuals with depressive symptom measurement	3p14.2	3	61096480	FHIT	FHIT			2272			rs9825823-?	rs9825823	0	9825823	intron_variant	0	NR	7E-10	9.154901959985743		6.2	Z score increase	Affymetrix, Illumina, Perlegen [918921] (imputed)	N
2014-04-01	24039173	McGrath LM	2013-09-13	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/24039173	Genetic predictors of risk and resilience in psychiatric disorders: a cross-disorder genome-wide association study of functional impairment in major depressive disorder, bipolar disorder, and schizophrenia.	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	2,246 European ancestry individuals	NA	3q24	3	147098924	intergenic	RNU6-505P - LOC107986139	106479790	107986139		102211	56916	rs4681346-?	rs4681346	0	4681346	intron_variant	1	NR	3E-6	5.522878745280337	(MCS)			Affymetrix [1633452] (imputed)	N
2014-04-01	24039173	McGrath LM	2013-09-13	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/24039173	Genetic predictors of risk and resilience in psychiatric disorders: a cross-disorder genome-wide association study of functional impairment in major depressive disorder, bipolar disorder, and schizophrenia.	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	2,246 European ancestry individuals	NA	1q23.3	1	161493797	FCGR2A, FCGR3A, HSPA6	LOC105371473			105371473			rs7535475-?	rs7535475	0	7535475	intergenic_variant	0	NR	3E-6	5.522878745280337	(MCS)			Affymetrix [1633452] (imputed)	N
2014-04-01	24039173	McGrath LM	2013-09-13	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/24039173	Genetic predictors of risk and resilience in psychiatric disorders: a cross-disorder genome-wide association study of functional impairment in major depressive disorder, bipolar disorder, and schizophrenia.	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	2,246 European ancestry individuals	NA	8q24.22	8	133462834	ST3GAL1	ST3GAL1			6482			rs2736871-?	rs2736871	0	2736871	intron_variant	0	NR	3E-6	5.522878745280337	(MCS)			Affymetrix [1633452] (imputed)	N
2014-04-01	24039173	McGrath LM	2013-09-13	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/24039173	Genetic predictors of risk and resilience in psychiatric disorders: a cross-disorder genome-wide association study of functional impairment in major depressive disorder, bipolar disorder, and schizophrenia.	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	2,246 European ancestry individuals	NA	5p15.32	5	5297087	ADAMTS16	ADAMTS16, LOC101929200			170690, 101929200			rs16875288-?	rs16875288	0	16875288	intron_variant	0	NR	6E-8	7.221848749616356	(PCS)			Affymetrix [1633452] (imputed)	N
2014-04-01	24039173	McGrath LM	2013-09-13	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/24039173	Genetic predictors of risk and resilience in psychiatric disorders: a cross-disorder genome-wide association study of functional impairment in major depressive disorder, bipolar disorder, and schizophrenia.	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	2,246 European ancestry individuals	NA	17p13.2	17	4104300	ZZEF1, CYB5D2, ANKFY1	ZZEF1			23140			rs7221595-?	rs7221595	0	7221595	intron_variant	0	NR	5E-6	5.301029995663981	(PCS)			Affymetrix [1633452] (imputed)	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	4p15.1	4	33623080	intergenic	LOC105374391 - LOC105374392	105374391	105374392		102646	258501	rs10517287-T	rs10517287	0	10517287	intergenic_variant	1	0.11	2E-7	6.698970004336019	(Citalopram+Bupropion, Vision/hearing-related side effects)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	15q25.3	15	86893514	AGBL1	AGBL1			123624			rs17647114-T	rs17647114	0	17647114	intron_variant	0	0.03	4E-7	6.3979400086720375	(Citalopram+Bupropion, Vision/hearing-related side effects)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	2p24.3	2	14257928	intergenic	LINC00276			100499171			rs16861531-G	rs16861531	0	16861531	intron_variant	0	0.03	7E-7	6.154901959985743	(Citalopram+Buspirone, Dizziness)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	3p26.3	3	130794	CHL1	LOC101927174, LOC107986057			101927174, 107986057			rs6795349-G	rs6795349	0	6795349	intergenic_variant	0	0.03	2E-6	5.698970004336019	(Citalopram+Buspirone, Dizziness)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	4p15.33	4	13115138	intergenic	LOC105374493 - LOC105374494	105374493	105374494		142108	31119	rs491376-C	rs491376	0	491376	intergenic_variant	1	0.01	2E-6	5.698970004336019	(Citalopram+Buspirone, Dizziness)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	4p15.33	4	13120911	intergenic	LOC105374493 - LOC105374494	105374493	105374494		147881	25346	rs573332-G	rs573332	0	573332	intergenic_variant	1	0.11	1E-6	6.0	(Citalopram+Buspirone, Dizziness)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	6q25.3	6	157620251	ZDHHC14	ZDHHC14			79683			rs2163287-A	rs2163287	0	2163287	intron_variant	0	0.02	3E-6	5.522878745280337	(Citalopram+Buspirone, Dizziness)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	8q21.13	8	82991579	intergenic	LOC101927141 - LOC100420845	101927141	100420845		29655	108397	rs7015622-C	rs7015622	0	7015622	intergenic_variant	1	0.01	1E-6	6.0	(Citalopram+Buspirone, Dizziness)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	9q34.11	9	129608081	C9orf50	LOC105376292 - NTMT1	105376292	28989		25395	803	rs10988449-T	rs10988449	0	10988449	upstream_gene_variant	1	0.17	3E-6	5.522878745280337	(Citalopram+Buspirone, Dizziness)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	15q21.2	15	49647649	DTWD1	DTWD1			56986			rs8039808-A	rs8039808	0	8039808	3_prime_UTR_variant	0	0.06	5E-7	6.301029995663981	(Citalopram+Buspirone, Dizziness)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	16p13.2	16	8279325	intergenic	LOC105371070 - LOC105371071	105371070	105371071		166691	17169	rs2034588-G	rs2034588	0	2034588	intron_variant	1	0.02	2E-6	5.698970004336019	(Citalopram+Buspirone, Dizziness)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	22q13.1	22	37586005	LGALS2	LGALS2 - GGA1	3957	26088		5988	21230	rs12157904-G	rs12157904	0	12157904	upstream_gene_variant	1	0.07	2E-6	5.698970004336019	(Citalopram+Buspirone, Dizziness)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	Xp21.1	X	31997259	DMD	DMD			1756			rs16990008-C	rs16990008	0	16990008	intron_variant	0	0.02	2E-6	5.698970004336019	(Citalopram+Buspirone, Dizziness)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	1p33	1	47453149	FOXD2	FOXD2 - RPL21P24	2306	100270880		12458	44713	rs527430-G	rs527430	0	527430	intergenic_variant	1	0.39	4E-7	6.3979400086720375	(Citalopram+Buspirone, General side effects)			Affymetrix [421789]	N
2015-05-14	22041458	Clark SL	2011-11-01	Psychol Med	www.ncbi.nlm.nih.gov/pubmed/22041458	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	Response to anti-depressant treatment in major depressive disorder	1,151 European ancestry cases, 288 African American cases	NA	8q24.21	8	127492252	POU5F1B	CASC8 - LOC105375754	727677	105375754		10113	172287	rs17766217-A	rs17766217	0	17766217	intergenic_variant	1	0.01	3E-7	6.522878745280337	(Citalopram+Buspirone, General side effects)			Affymetrix [421789]	N
2010-09-28	20800221	Terracciano A	2010-08-25	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20800221	Genome-wide association scan of trait depression.	Depression (quantitative trait)	3,972 Sardinian individuals, 839 European ancestry individuals	NA	15q22.2	15	60974897	RORA	RORA			6095			rs12912233-T	rs12912233	0	12912233	intron_variant	0	0.46	6E-7	6.221848749616356		0.15	[NR] unit increase	Affymetrix, Illumina [up to 2500000] (imputed)	N
2010-09-28	20800221	Terracciano A	2010-08-25	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20800221	Genome-wide association scan of trait depression.	Depression (quantitative trait)	3,972 Sardinian individuals, 839 European ancestry individuals	NA	17q12	17	35516493	SLFN12L	SLFN12L			100506736			rs8070473-T	rs8070473	0	8070473	intron_variant	0	0.32	2E-6	5.698970004336019		0.16	[NR] unit decrease	Affymetrix, Illumina [up to 2500000] (imputed)	N
2010-09-28	20800221	Terracciano A	2010-08-25	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20800221	Genome-wide association scan of trait depression.	Depression (quantitative trait)	3,972 Sardinian individuals, 839 European ancestry individuals	NA	5p14.3	5	19440059	CDH18	HSPD1P15 - CDH18	646273	1016		205854	32871	rs349475-T	rs349475	0	349475	intergenic_variant	1	0.29	2E-6	5.698970004336019		0.18	[NR] unit increase	Affymetrix, Illumina [up to 2500000] (imputed)	N
2010-09-28	20800221	Terracciano A	2010-08-25	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20800221	Genome-wide association scan of trait depression.	Depression (quantitative trait)	3,972 Sardinian individuals, 839 European ancestry individuals	NA	11p15.4	11	7993230	EIF3F	EIF3F			8665			rs12420464-T	rs12420464	0	12420464	intron_variant	0	0.04	3E-6	5.522878745280337		0.38	[NR] unit decrease	Affymetrix, Illumina [up to 2500000] (imputed)	N
2010-09-28	20800221	Terracciano A	2010-08-25	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20800221	Genome-wide association scan of trait depression.	Depression (quantitative trait)	3,972 Sardinian individuals, 839 European ancestry individuals	NA	13q33.3	13	107127968	FAM155A	LOC105370350			105370350			rs1927745-A	rs1927745	0	1927745	intergenic_variant	0	0.24	5E-6	5.301029995663981		0.16	[NR] unit decrease	Affymetrix, Illumina [up to 2500000] (imputed)	N
2010-09-28	20800221	Terracciano A	2010-08-25	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20800221	Genome-wide association scan of trait depression.	Depression (quantitative trait)	3,972 Sardinian individuals, 839 European ancestry individuals	NA	16q23.3	16	83250733	CDH13	CDH13			1012			rs10514585-A	rs10514585	0	10514585	intron_variant	0	0.31	5E-6	5.301029995663981		0.15	[NR] unit increase	Affymetrix, Illumina [up to 2500000] (imputed)	N
2010-09-28	20800221	Terracciano A	2010-08-25	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20800221	Genome-wide association scan of trait depression.	Depression (quantitative trait)	3,972 Sardinian individuals, 839 European ancestry individuals	NA	10p11.22	10	33005847	ITGB1	LOC101929475			101929475			rs11009175-A	rs11009175	0	11009175	intron_variant	0	0.17	5E-6	5.301029995663981		0.16	[NR] unit increase	Affymetrix, Illumina [up to 2500000] (imputed)	N
2010-09-28	20800221	Terracciano A	2010-08-25	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20800221	Genome-wide association scan of trait depression.	Depression (quantitative trait)	3,972 Sardinian individuals, 839 European ancestry individuals	NA	7q31.33	7	126999550	GRM8	GRM8			2918			rs17864092-T	rs17864092	0	17864092	intron_variant	0	0.90	6E-6	5.221848749616356		0.17	[NR] unit decrease	Affymetrix, Illumina [up to 2500000] (imputed)	N
2010-09-28	20800221	Terracciano A	2010-08-25	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20800221	Genome-wide association scan of trait depression.	Depression (quantitative trait)	3,972 Sardinian individuals, 839 European ancestry individuals	NA	2p24.1	2	23191780	intergenic	LOC107985792			107985792			rs1449984-A	rs1449984	0	1449984	intron_variant	0	0.72	7E-6	5.154901959985743		0.15	[NR] unit decrease	Affymetrix, Illumina [up to 2500000] (imputed)	N
2010-09-28	20800221	Terracciano A	2010-08-25	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20800221	Genome-wide association scan of trait depression.	Depression (quantitative trait)	3,972 Sardinian individuals, 839 European ancestry individuals	NA	12q24.32	12	127329196	intergenic	LOC101927616			101927616			rs10744304-A	rs10744304	0	10744304	intron_variant	0	0.63	9E-6	5.045757490560675		0.15	[NR] unit decrease	Affymetrix, Illumina [up to 2500000] (imputed)	N
2010-09-28	20800221	Terracciano A	2010-08-25	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20800221	Genome-wide association scan of trait depression.	Depression (quantitative trait)	3,972 Sardinian individuals, 839 European ancestry individuals	NA	10q22.1	10	68952306	DDX21	DDX50			79009			rs2017305-A	rs2017305	0	2017305	upstream_gene_variant	0	0.92	9E-6	5.045757490560675		0.22	[NR] unit decrease	Affymetrix, Illumina [up to 2500000] (imputed)	N
2013-04-09	23290196	Hek K	2013-01-02	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23290196	A genome-wide association study of depressive symptoms.	Depression (quantitative trait)	up to 34,549 European ancestry individuals	up to 16,709 European ancestry individuals	5q21.2	5	104734216	NUDT12	LOC105379109			105379109			rs161645-A	rs161645	0	161645	intron_variant	0	0.34	8E-8	7.096910013008056				Affymetrix, Illumina [2391896] (imputed)	N
2013-04-09	23290196	Hek K	2013-01-02	Biol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23290196	A genome-wide association study of depressive symptoms.	Depression (quantitative trait)	up to 34,549 European ancestry individuals	up to 16,709 European ancestry individuals	14q23.3	14	66987141	GPHN	GPHN			10243			rs8020095-A	rs8020095	0	8020095	intron_variant	0	0.17	3E-6	5.522878745280337				Affymetrix, Illumina [2391896] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to antidepressants in depression	7,795 European ancestry responder cases, 1,311 European ancestry non-responder cases	NA	2p22.3	2	33601810	FAM98A, MYADML	LOC105374455			105374455			rs1375194-?	rs1375194	0	1375194	upstream_gene_variant	0		2E-7	6.698970004336019		1.2578616	[1.15-1.37]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to antidepressants in depression	7,795 European ancestry responder cases, 1,311 European ancestry non-responder cases	NA	2q14.1	2	115195009	DPP10	DPP10			57628			rs190662943-?	rs190662943	0	190662943	intron_variant	0		7E-7	6.154901959985743		14.419	[5.177-40.161]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to antidepressants in depression	7,795 European ancestry responder cases, 1,311 European ancestry non-responder cases	NA	1q42.13	1	229213737	RHOU, RAB4A	LOC105373158 - LOC102723935	105373158	102723935		29274	24052	rs75507262-?	rs75507262	0	75507262	intergenic_variant	1		1E-6	6.0		2.3255813	[1.69-3.21]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to antidepressants in depression	7,795 European ancestry responder cases, 1,311 European ancestry non-responder cases	NA	12q24.32	12	127251320	Intergenic	LOC105370064 - LOC105370065	105370064	105370065		45401	22945	rs10847303-?	rs10847303	0	10847303	intergenic_variant	1		2E-6	5.698970004336019		1.242236	[1.14-1.36]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to antidepressants in depression	7,795 European ancestry responder cases, 1,311 European ancestry non-responder cases	NA	20p13	20	3996678	RNF24	RNF24			11237			rs73086581-?	rs73086581	0	73086581	intron_variant	0		2E-6	5.698970004336019		1.299	[1.169-1.444]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to antidepressants and depression	1,311 European ancestry non-responder cases, 192,178 European ancestry healthy controls	NA	21q22.2	21	38360474	KCNJ15, ERG	LOC107985513 - ERG	107985513	2078		4545	6787	rs190544851-?	rs190544851	0	190544851	intergenic_variant	1		3E-7	6.522878745280337		14.29	[3.555-57.454]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to antidepressants and depression	1,311 European ancestry non-responder cases, 192,178 European ancestry healthy controls	NA	6q25.3	6	158893901	C6orf99	C6orf99			100130967			rs57043326-?	rs57043326	0	57043326	intron_variant	0		8E-7	6.096910013008056		2.65252	[1.69-4.17]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to antidepressants and depression	1,311 European ancestry non-responder cases, 192,178 European ancestry healthy controls	NA	1p36.21	1	14959860	KAZN	KAZN			23254			rs12068879-?	rs12068879	0	12068879	intron_variant	0		1E-6	6.0		2.221	[1.667-2.958]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to antidepressants and depression	1,311 European ancestry non-responder cases, 192,178 European ancestry healthy controls	NA	9p23	9	10582445	PTPRD	PTPRD			5789			rs1322281-?	rs1322281	0	1322281	intron_variant	0		1E-6	6.0		1.242	[1.139-1.354]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to antidepressants and depression	1,311 European ancestry non-responder cases, 192,178 European ancestry healthy controls	NA	2p22.3	2	33575832	RASGRP3, FAM98A	LOC105374454 - FAM98A	105374454	25940		6402	7829	rs13418410-?	rs13418410	0	13418410	intergenic_variant	1		2E-6	5.698970004336019		1.212	[1.121-1.311]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to antidepressants and depression	7,795 European ancestry responder cases, 191,173 European ancestry healthy controls	NA	12q13.13	12	51525350	SLC4A8, SCN8A	SLC4A8 - SCN8A	9498	6334		9587	64609	rs34807503-?	rs34807503	0	34807503	intergenic_variant	1		5E-7	6.301029995663981		1.0905125	[1.05-1.13]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to antidepressants and depression	7,795 European ancestry responder cases, 191,173 European ancestry healthy controls	NA	7q32.2	7	129765934	NRF1, UBE2H	LOC105375501			105375501			rs2402960-?	rs2402960	0	2402960	downstream_gene_variant	0		8E-7	6.096910013008056		1.098901	[1.06-1.14]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to antidepressants and depression	7,795 European ancestry responder cases, 191,173 European ancestry healthy controls	NA	16q21	16	62031776	CDH8	CDH8			1006			rs200312707-?	rs200312707	0	200312707	intron_variant	0		1E-6	6.0		1.0881393	[1.05-1.13]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to antidepressants and depression	7,795 European ancestry responder cases, 191,173 European ancestry healthy controls	NA	1p36.23	1	8018249	ERRFI1	ERRFI1			54206			rs400736-?	rs400736	0	400736	intron_variant	0		2E-6	5.698970004336019		1.0857763	[1.05-1.12]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to antidepressants and depression	7,795 European ancestry responder cases, 191,173 European ancestry healthy controls	NA	1p32.3	1	53807606	NDC1	NDC1			55706			rs35265457-?	rs35265457	0	35265457	intron_variant	0		2E-6	5.698970004336019		1.508	[1.261-1.803]	Illumina [~ 12000000] (imputed)	N
2016-06-13	26348319	Myung W	2015-09-08	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/26348319	A genome-wide association study of antidepressant response in Koreans.	Response to serotonin reuptake inhibitors in non-psychotic unipolar depression	263 Korean ancestry responder cases, 218 Korean ancestry non-responder cases	118 Korean ancestry responder cases, 112 Korean ancestry non-responder cases	7q11.22	7	69944392	AUTS2	AUTS2			26053			rs7785360-?	rs7785360	0	7785360	intron_variant	0	NR	2E-8	7.698970004336019				Affymetrix [505435] (imputed)	N
2016-06-13	26348319	Myung W	2015-09-08	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/26348319	A genome-wide association study of antidepressant response in Koreans.	Response to serotonin reuptake inhibitors in non-psychotic unipolar depression	263 Korean ancestry responder cases, 218 Korean ancestry non-responder cases	118 Korean ancestry responder cases, 112 Korean ancestry non-responder cases	1q44	1	245699920	KIF26B, SMYD3	KIF26B			55083			rs10924309-?	rs10924309	0	10924309	intron_variant	0	NR	6E-6	5.221848749616356				Affymetrix [505435] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to bupropion in depression	2,675 European ancestry responder cases, 1,861 European ancestry non-responder cases	NA	4q22.1	4	89500202	GPRIN3, SNCA	LOC105377328 - LOC105377329	105377328	105377329		14643	51131	rs1908557-T	rs1908557	0	1908557	intergenic_variant	1		3E-8	7.522878745280337		1.348	[1.213-1.497]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to bupropion in depression	2,675 European ancestry responder cases, 1,861 European ancestry non-responder cases	NA	14q13.2	14	34840969	BAZ1A	BAZ1A			11177			rs77945277-?	rs77945277	0	77945277	intron_variant	0		2E-7	6.698970004336019		11.111111	[3.83-32.26]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to bupropion in depression	2,675 European ancestry responder cases, 1,861 European ancestry non-responder cases	NA	1p13.3	1	110479338	PROK1, KCNA10	LOC105378898 - CYMP	105378898	643160		5256	1428	rs4839421-?	rs4839421	0	4839421	intron_variant	1		5E-7	6.301029995663981		1.249	[1.146-1.362]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to bupropion in depression	2,675 European ancestry responder cases, 1,861 European ancestry non-responder cases	NA	11p12	11	42785177	API5	LOC105376642 - LOC100533710	105376642	100533710		523162	278454	rs75995702-?	rs75995702	0	75995702	intergenic_variant	1		7E-7	6.154901959985743		12.857	[3.496-47.288]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to bupropion in depression	2,675 European ancestry responder cases, 1,861 European ancestry non-responder cases	NA	8p23.2	8	5364506	CSMD1	LOC107986907 - RPL23AP54	107986907	100271466		218659	112003	rs34102224-?	rs34102224	0	34102224	downstream_gene_variant	1		1E-6	6.0		1.354	[1.197-1.531]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to selective serotonin reuptake inhibitors in depression	6,348 European ancestry responder cases, 3,340 European ancestry non-responder cases	NA	5p13.1	5	38464142	EGFLAM	EGFLAM			133584			rs80164876-?	rs80164876	0	80164876	3_prime_UTR_variant	0		4E-7	6.3979400086720375		2.09	[1.551-2.815]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to selective serotonin reuptake inhibitors in depression	6,348 European ancestry responder cases, 3,340 European ancestry non-responder cases	NA	22q11.22	22	22047895	TOP3B, VPREB1	IGL			3535			rs114465512-?	rs114465512	0	114465512	intron_variant	0		5E-7	6.301029995663981		12.987013	[3.98-43.48]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to selective serotonin reuptake inhibitors in depression	6,348 European ancestry responder cases, 3,340 European ancestry non-responder cases	NA	14q32.12	14	91472532	SMEK1	SMEK1			55671			rs35863382-?	rs35863382	0	35863382	intron_variant	0		7E-7	6.154901959985743		1.540832	[1.3-1.83]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to selective serotonin reuptake inhibitors in depression	6,348 European ancestry responder cases, 3,340 European ancestry non-responder cases	NA	18q21.1	18	49694188	LIPG, ACAA2	LOC105372112			105372112			rs117198528-?	rs117198528	0	117198528	intergenic_variant	0		9E-7	6.045757490560675		1.823	[1.437-2.313]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to selective serotonin reuptake inhibitors in depression	6,348 European ancestry responder cases, 3,340 European ancestry non-responder cases	NA	19q13.33	19	47657765	GLTSCR1	GLTSCR1			29998			rs138472420-?	rs138472420	0	138472420	intron_variant	0		1E-6	6.0		5.628	[2.692-11.767]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to citalopram or escitalopram in depression	2,963 European ancestry responder cases, 2,005 European ancestry non-responder cases	NA	1p21.2	1	99463578	LPPR4, PALMD	LOC107985093 - LOC107985421	107985093	107985421		26363	119	rs111365677-?	rs111365677	0	111365677	upstream_gene_variant	1		1E-7	7.0		17.54386	[4.33-71.43]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to citalopram or escitalopram in depression	2,963 European ancestry responder cases, 2,005 European ancestry non-responder cases	NA	3q23	3	141059454	SPSB4	SPSB4			92369			rs142484554-?	rs142484554	0	142484554	intron_variant	0		3E-7	6.522878745280337		1.459854	[1.26-1.69]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to citalopram or escitalopram in depression	2,963 European ancestry responder cases, 2,005 European ancestry non-responder cases	NA	10q24.33	10	103390184	USMG5	USMG5			84833			rs188843168-?	rs188843168	0	188843168	intron_variant	0		4E-7	6.3979400086720375		449.83	[5.402-Inf]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to citalopram or escitalopram in depression	2,963 European ancestry responder cases, 2,005 European ancestry non-responder cases	NA	2p13.3	2	70415675	FAM136A, TGFA	LOC105374793			105374793			rs6546604-?	rs6546604	0	6546604	intron_variant	0		5E-7	6.301029995663981		1.2787724	[1.16-1.41]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to citalopram or escitalopram in depression	2,963 European ancestry responder cases, 2,005 European ancestry non-responder cases	NA	4p14	4	40985283	APBB2	APBB2, LOC107986273			323, 107986273			rs34177316-?	rs34177316	0	34177316	intron_variant	0		6E-7	6.221848749616356		1.355	[1.203-1.528]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to citalopram or escitalopram in depression	2,963 European ancestry responder cases, 2,005 European ancestry non-responder cases	NA	11q24.1	11	123680000	SCN3B, ZNF202	LOC105369543 - ZNF202	105369543	7753		7000	43927	rs201921722-?	rs201921722	0	201921722	intergenic_variant	1		7E-7	6.154901959985743		1.2642225	[1.15-1.39]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to citalopram or escitalopram in depression	2,963 European ancestry responder cases, 2,005 European ancestry non-responder cases	NA	6p12.3	6	50758466	TFAP2D	TFAP2D			83741			rs80278479-?	rs80278479	0	80278479	intron_variant	0		8E-7	6.096910013008056		14.492754	[3.88-55.56]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to bupropion and depression	2,675 European ancestry responder cases, 191,986 European ancestry healthy controls	NA	12p12.1	12	26124961	BHLHE41	BHLHE41, SSPN			79365, 8082			rs200855945-?	rs200855945	0	200855945	5_prime_UTR_variant	0		4E-7	6.3979400086720375		4.929	[2.35-10.34]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to bupropion and depression	2,675 European ancestry responder cases, 191,986 European ancestry healthy controls	NA	4q35.1	4	184084475	STOX2, ENPP6	LOC100421006 - ENPP6	100421006	133121		11276	4231	rs112538845-?	rs112538845	0	112538845	downstream_gene_variant	1		6E-7	6.221848749616356		1.637	[1.366-1.961]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to bupropion and depression	2,675 European ancestry responder cases, 191,986 European ancestry healthy controls	NA	2q36.2	2	224600060	CUL3, DOCK10	CUL3 - LOC105373909	8452	105373909		14663	3751	rs78087832-?	rs78087832	0	78087832	intergenic_variant	1		6E-7	6.221848749616356		2.731	[1.933-3.857]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to bupropion and depression	2,675 European ancestry responder cases, 191,986 European ancestry healthy controls	NA	9q33.1	9	115094539	TNC	TNC			3371			rs112106319-?	rs112106319	0	112106319	intron_variant	0		1E-6	6.0		2.3255813	[1.59-3.4]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to bupropion and depression	2,675 European ancestry responder cases, 191,986 European ancestry healthy controls	NA	12q21.2	12	77503518	E2F7, NAV3	LOC105369856 - NAV3	105369856	89795		116486	68344	rs73425402-?	rs73425402	0	73425402	intron_variant	1		1E-6	6.0		20.833332	[8.26-52.63]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to selective serotonin reuptake inhibitors and depression	3,340 European ancestry non-responder cases, 191,882  European ancestry healthy controls	NA	11p15.3	11	12065766	DKK3, MICAL2	LOC105376554 - MICAL2	105376554	9645		3981	44810	rs1994321-?	rs1994321	0	1994321	upstream_gene_variant	1		5E-7	6.301029995663981		1.1547344	[1.09-1.22]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to selective serotonin reuptake inhibitors and depression	3,340 European ancestry non-responder cases, 191,882  European ancestry healthy controls	NA	2p25.1	2	9788024	YWHAQ, TAF1B	LOC100996549 - LOC105373421	100996549	105373421		9460	17286	rs113378111-?	rs113378111	0	113378111	regulatory_region_variant	1		7E-7	6.154901959985743		1.579	[1.303-1.912]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to selective serotonin reuptake inhibitors and depression	3,340 European ancestry non-responder cases, 191,882  European ancestry healthy controls	NA	5q31.1	5	133429517	FSTL4	FSTL4			23105			rs73788091-?	rs73788091	0	73788091	intron_variant	0		1E-6	6.0		3.011	[2.044-4.437]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to selective serotonin reuptake inhibitors and depression	3,340 European ancestry non-responder cases, 191,882  European ancestry healthy controls	NA	18q22.1	18	67366441	CDH19, DSEL	RPL31P9 - DSEL	619464	92126		228683	140141	rs9951011-?	rs9951011	0	9951011	intergenic_variant	1		2E-6	5.698970004336019		1.1806375	[1.1-1.26]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to selective serotonin reuptake inhibitors and depression	3,340 European ancestry non-responder cases, 191,882  European ancestry healthy controls	NA	1q31.2	1	190812369	FAM5C	LOC440704 - HNRNPA1P46	440704	100421399		10711	333254	rs78620960-?	rs78620960	0	78620960	intergenic_variant	1		2E-6	5.698970004336019		1.2033695	[1.12-1.3]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to selective serotonin reuptake inhibitors and depression	6,348 European ancestry responder cases, 191,357 European ancestry healthy controls	NA	4q31.23	4	150101495	DCLK2	DCLK2			166614			rs150175932-?	rs150175932	0	150175932	intron_variant	0		1E-7	7.0		15.22	[3.318-69.804]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to selective serotonin reuptake inhibitors and depression	6,348 European ancestry responder cases, 191,357 European ancestry healthy controls	NA	8q12.1	8	56934154	IMPAD1, PENK	RNU6-13P - IMPAD1	106480423	54928		16965	23775	rs141746753-?	rs141746753	0	141746753	intergenic_variant	1		1E-6	6.0		3.2467532	[1.84-5.71]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to selective serotonin reuptake inhibitors and depression	6,348 European ancestry responder cases, 191,357 European ancestry healthy controls	NA	7q31.33	7	125794995	POT1, GRM8	LOC100506664 - LOC105375487	100506664	105375487		328685	50218	rs73720034-?	rs73720034	0	73720034	intergenic_variant	1		1E-6	6.0		1.256	[1.142-1.381]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to selective serotonin reuptake inhibitors and depression	6,348 European ancestry responder cases, 191,357 European ancestry healthy controls	NA	2p16.1	2	58620818	FANCL	LINC01122			400955			rs6545694-?	rs6545694	0	6545694	intron_variant	0		2E-6	5.698970004336019		1.096	[1.056-1.137]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to selective serotonin reuptake inhibitors and depression	6,348 European ancestry responder cases, 191,357 European ancestry healthy controls	NA	2p25.3	2	2696619	MYT1L, TSSC1	LOC107985839 - LOC105373390	107985839	105373390		32469	134777	rs61519662-?	rs61519662	0	61519662	intergenic_variant	1		2E-6	5.698970004336019		1.1013216	[1.06-1.15]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to citalopram or escitalopram and depression	2,005 European ancestry non-responder cases, 192,083 European ancestry healthy controls	NA	20q13.13	20	49065345	CSE1L	CSE1L			1434			rs6063349-?	rs6063349	0	6063349	intron_variant	0		7E-7	6.154901959985743		1.183432	[1.11-1.27]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to citalopram or escitalopram and depression	2,005 European ancestry non-responder cases, 192,083 European ancestry healthy controls	NA	11p13	11	33109861	CSTF3	CSTF3			1479			rs142641502-?	rs142641502	0	142641502	intron_variant	0		8E-7	6.096910013008056		4.565	[2.155-9.671]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to citalopram or escitalopram and depression	2,005 European ancestry non-responder cases, 192,083 European ancestry healthy controls	NA	6p25.3	6	1402916	FOXF2, FOXC1	FOXF2 - LOC102723944	2295	102723944		7319	50371	rs201569130-?	rs201569130	0	201569130	intergenic_variant	1		9E-7	6.045757490560675		3.009	[1.785-5.073]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to citalopram or escitalopram and depression	2,005 European ancestry non-responder cases, 192,083 European ancestry healthy controls	NA	15q23	15	69934284	RPLP1, TLE3	LINC00593 - LOC101929129	414926	101929129		91317	38193	rs1548076-?	rs1548076	0	1548076	intergenic_variant	1		1E-6	6.0		2.4937656	[1.63-3.82]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to citalopram or escitalopram and depression	2,005 European ancestry non-responder cases, 192,083 European ancestry healthy controls	NA	11q13.2	11	67449378	CORO1B, GPR152	CORO1B - GPR152	57175	390212		5557	1923	rs182377406-?	rs182377406	0	182377406	upstream_gene_variant	1		1E-6	6.0		5.773	[3.250-10.254]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to citalopram or escitalopram and depression	2,963 European ancestry responder cases, 191,936 European ancestry healthy controls	NA	11q14.1	11	80671683	Intergenic	ARL6IP1P3 - LOC105369409	729790	105369409		17611	37544	rs74860738-?	rs74860738	0	74860738	intergenic_variant	1		3E-7	6.522878745280337		1.2870014	[1.17-1.41]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to citalopram or escitalopram and depression	2,963 European ancestry responder cases, 191,936 European ancestry healthy controls	NA	20p11.23	20	19165806	C20orf78, SLC24A3	LOC107985442 - LOC101929547	107985442	101929547		111939	43188	rs143934587-?	rs143934587	0	143934587	intergenic_variant	1		7E-7	6.154901959985743		6.711409	[3.61-12.5]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to citalopram or escitalopram and depression	2,963 European ancestry responder cases, 191,936 European ancestry healthy controls	NA	4q12	4	52767390	ERVMER34-1, RASL11B	LOC107986281 - LOC152578	107986281	152578		13818	22604	rs189864513-?	rs189864513	0	189864513	intergenic_variant	1		8E-7	6.096910013008056		12.345678	[5.65-27.03]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to citalopram or escitalopram and depression	2,963 European ancestry responder cases, 191,936 European ancestry healthy controls	NA	3q27.3	3	186353656	DGKG	DGKG			1608			rs11924809-?	rs11924809	0	11924809	intron_variant	0		1E-6	6.0		1.215	[1.122-1.316]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Response to citalopram or escitalopram and depression	2,963 European ancestry responder cases, 191,936 European ancestry healthy controls	NA	10q24.33	10	103161907	NT5C2	NT5C2			22978			rs117375960-?	rs117375960	0	117375960	intron_variant	0		2E-6	5.698970004336019		142.85713	[2.9-]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to bupropion and depression	1,861 European ancestry non-responder cases, 192,070 European ancestry healthy controls	NA	Xq27.2	X	142772620	SPANXN4, MAGEC2	LOC105373345 - SPANXN4	105373345	441525		147964	253298	rs190783615-?	rs190783615	0	190783615	intergenic_variant	1		2E-17	16.69897000433602		15.18	[3.095-74.439]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to bupropion and depression	1,861 European ancestry non-responder cases, 192,070 European ancestry healthy controls	NA	5p13.1	5	39203496	FYB	FYB			2533			rs201203751-?	rs201203751	0	201203751	intron_variant	0		5E-7	6.301029995663981		4.009	[2.537-6.336]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to bupropion and depression	1,861 European ancestry non-responder cases, 192,070 European ancestry healthy controls	NA	17q11.2	17	28110028	NLK	NLK			51701			rs183124483-?	rs183124483	0	183124483	intron_variant	0		6E-7	6.221848749616356		14.925372	[6.85-32.26]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to bupropion and depression	1,861 European ancestry non-responder cases, 192,070 European ancestry healthy controls	NA	5p12	5	45757459	HCN1	HCN1 - EMB	348980	133418		61341	4638733	rs56388524-?	rs56388524	0	56388524	intergenic_variant	1		7E-7	6.154901959985743		1.798	[1.451-2.228]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to bupropion and depression	1,861 European ancestry non-responder cases, 192,070 European ancestry healthy controls	NA	5q12.3	5	65459777	ADAMTS6	ADAMTS6			11174			rs143405544-?	rs143405544	0	143405544	intron_variant	0		7E-7	6.154901959985743		6.711409	[2.44-18.52]	Illumina [~ 12000000] (imputed)	N
2017-03-24	27622933	Li QS	2016-09-13	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/27622933	Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.	Non-response to bupropion and depression	1,861 European ancestry non-responder cases, 192,070 European ancestry healthy controls	NA	20q12	20	41197420	ZHX3	ZHX3			23051			rs183042538-?	rs183042538	0	183042538	intron_variant	0		8E-7	6.096910013008056		1.431	[1.249-1.638]	Illumina [~ 12000000] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	20p13	20	614136	NR	TCF15 - LOC107985387	6939	107985387		3870	25868	rs1533087-T	rs1533087	0	1533087	upstream_gene_variant	1		9E-6	5.045757490560675	(Modelling analysis)	1.06	[1.03-1.09]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	7p22.3	7	2001797	NR	MAD1L1			8379			rs1107592-A	rs1107592	0	1107592	intron_variant	0		5E-6	5.301029995663981	(Modelling analysis)	1.06	[1.03-1.09]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	10p14	10	6904301	intergenic	LOC105376387			105376387			rs6602217-T	rs6602217	0	6602217	intron_variant	0		2E-6	5.698970004336019	(Modelling analysis)	1.12	[1.07-1.17]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	16p13.2	16	9581389	intergenic	LOC101927026			101927026			rs12325410-T	rs12325410	0	12325410	intron_variant	0		1E-6	6.0	(Modelling analysis)	1.09	[1.05-1.13]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	16p13.2	16	9817529	GRIN2A	GRIN2A			2903			rs8058295-A	rs8058295	0	8058295	intron_variant	0		7E-6	5.154901959985743	(Modelling analysis)	1.06	[1.04-1.09]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	19p13.12	19	14602681	NR	CLEC17A, ADGRE3			388512, 84658			rs7254215-A	rs7254215	0	7254215	intron_variant	0		7E-6	5.154901959985743	(Modelling analysis)	1.09	[1.05-1.13]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	10p12.32	10	18312999	CACNB2	CACNB2			783			rs2799573 -?	rs2799573	0	2799573	intron_variant	0	0.715	4E-8	7.3979400086720375	(Modelling analysis)	1.08	[1.05-1.12]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	16p12.2	16	23629146	NR	PALB2			79728			rs249954-A	rs249954	0	249954	intron_variant	0		2E-6	5.698970004336019	(Modelling analysis)	1.07	[1.04-1.10]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	7p15.3	7	24652933	intergenic	MPP6			51678			rs2721800-C	rs2721800	0	2721800	intron_variant	0		6E-7	6.221848749616356	(Modelling analysis)	1.08	[1.05-1.12]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	1p35.2	1	29964421	intergenic	LOC107984934 - LOC101929406	107984934	101929406		275124	49531	rs6694545-A	rs6694545	0	6694545	intergenic_variant	1		1E-6	6.0	(Modelling analysis)	1.07	[1.04-1.11]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	6p21.32	6	32707332	intergenic	MTCO3P1 - LOC102725019	404026	102725019		529	10835	rs9275524-T	rs9275524	0	9275524	upstream_gene_variant	1		2E-7	6.698970004336019	(Modelling analysis)	1.07	[1.04-1.09]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	8p12	8	34379474	intergenic	RPL10AP3 - LINC01288	137107	103689844		55799	404447	rs2609653-T	rs2609653	0	2609653	intergenic_variant	1		3E-6	5.522878745280337	(Modelling analysis)	1.13	[1.07-1.19]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	3p22.2	3	36801132	NR	LOC105377030 - LOC105377031	105377030	105377031		16847	18151	rs13072940-A	rs13072940	0	13072940	intergenic_variant	1		9E-6	5.045757490560675	(Modelling analysis)	1.06	[1.03-1.08]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	18q21.2	18	55153893	intergenic	RNA5SP459 - TCF4	100873703	6925		7248	68438	rs9951150-A	rs9951150	0	9951150	intergenic_variant	1		6E-7	6.221848749616356	(Modelling analysis)	1.06	[1.04-1.09]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	18q21.2	18	55399097	TCF4	TCF4			6925			rs11152369-A	rs11152369	0	11152369	intron_variant	0	NR	2E-7	6.698970004336019	(Modelling analysis)	1.19	[1.12-1.28]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	3p21.1	3	52699090	NR	GLT8D1			55830			rs6765687-T	rs6765687	0	6765687	intron_variant	0		5E-6	5.301029995663981	(Modelling analysis)	1.07	[1.04-1.11]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	3p21.1	3	52799203	ITIH3	ITIH3			3699			rs2535629-?	rs2535629	0	2535629	intron_variant	0	0.651	3E-12	11.522878745280337		1.1	[1.07-1.12]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	1p31.1	1	78798120	ELTD1	LOC652549 - ADGRL4	652549	64123		47264	91644	rs10873998-T	rs10873998	0	10873998	intergenic_variant	1		4E-6	5.3979400086720375	(Modelling analysis)	1.06	[1.03-1.09]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	15q25.3	15	88180481	NTRK3	NTRK3			4916			rs1104918-T	rs1104918	0	1104918	intron_variant	0		6E-6	5.221848749616356	(Modelling analysis)	1.07	[1.04-1.10]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	16q24.3	16	89675088	NR	SPATA33 - LOC105371416	124045	105371416		4630	7419	rs12443954-A	rs12443954	0	12443954	downstream_gene_variant	1		1E-6	6.0	(Modelling analysis)	1.08	[1.04-1.11]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	12q23.1	12	99104409	ANKS1B	LOC101928937, ANKS1B			101928937, 56899			rs10860392-T	rs10860392	0	10860392	intron_variant	0		2E-6	5.698970004336019	(Modelling analysis)	1.06	[1.04-1.09]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	1p21.3	1	98037378	DPYD, MIR137	MIR137HG			400765			rs1625579-?	rs1625579	0	1625579	intron_variant	0	0.801	2E-11	10.698970004336019	(Modelling analysis)			NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	2q11.2	2	102047167	MAP4K4, IL1R2	LOC107985926 - IL1R1	107985926	3554		1709	22471	rs2310173-T	rs2310173	0	2310173	intergenic_variant	1		3E-6	5.522878745280337	(Modelling analysis)	1.06	[1.03-1.08]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	4q24	4	101668126	BANK1	LOC105377346 - LOC107986297	105377346	107986297		17965	21321	rs7700191-A	rs7700191	0	7700191	intron_variant	1		4E-6	5.3979400086720375	(Modelling analysis)	1.12	[1.06-1.17]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	10q24.32	10	102900247	AS3MT	LOC107984265, C10orf32-ASMT, AS3MT			107984265, 100528007, 57412			rs11191454-?	rs11191454	0	11191454	intron_variant	0	0.91	1E-8	8.0		1.13	[1.08-1.18]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	10q24.33	10	103538013	NR	NEURL1			9148			rs7069733-C	rs7069733	0	7069733	intron_variant	0		7E-6	5.154901959985743	(Modelling analysis)	1.08	[1.04-1.12]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	8q23.1	8	105130105	ZFPM2	LOC105375695			105375695			rs9297357-T	rs9297357	0	9297357	intron_variant	0	NR	4E-7	6.3979400086720375	(Modelling analysis)	1.07	[1.04-1.10]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	11q22.3	11	107885825	SLC35F2, RAB39	SLC35F2 - RPLP2P3	54733	643949		26637	22522	rs2186903-A	rs2186903	0	2186903	intron_variant	1		4E-6	5.3979400086720375	(Modelling analysis)	1.07	[1.04-1.11]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	13q33.3	13	108016199	FAM155A	FAM155A - LIG4	728215	3981		148944	191243	rs12871532-T	rs12871532	0	12871532	intergenic_variant	1		1E-6	6.0	(Modelling analysis)	1.06	[1.04-1.09]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	7q31.1	7	110407907	intergenic	LOC105375451			105375451			rs4730430-T	rs4730430	0	4730430	intergenic_variant	0		3E-6	5.522878745280337	(Modelling analysis)	1.06	[1.03-1.08]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	5q23.3	5	131078288	NR	LOC105379172 - HINT1	105379172	3094		9740	80995	rs6867265-A	rs6867265	0	6867265	intergenic_variant	1		2E-6	5.698970004336019	(Modelling analysis)	1.11	[1.06-1.16]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	7q33	7	138174020	intergenic	LOC107986749 - RPS17P12	107986749	442726		8548	124041	rs10255295-A	rs10255295	0	10255295	upstream_gene_variant	1		5E-6	5.301029995663981	(Modelling analysis)	1.1	[1.06-1.14]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	5q32	5	146845681	PPP2R2B	PPP2R2B			5521			rs609412-A	rs609412	0	609412	intron_variant	0		2E-6	5.698970004336019	(Modelling analysis)	1.07	[1.04-1.10]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	6q25.2	6	152469438	SYNE1	SYNE1			23345			rs9371601-?	rs9371601	0	9371601	intron_variant	0	0.346	4E-9	8.397940008672037	(Modelling analysis)			NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	4q31.3	4	151987017	intergenic	RNA5SP169 - LOC100996286	100873434	100996286		15404	113736	rs360932-A	rs360932	0	360932	intergenic_variant	1		8E-6	5.096910013008056	(Modelling analysis)	1.06	[1.03-1.08]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	2q31.3	2	180212022	intergenic	LOC105373767 - LOC105373768	105373767	105373768		86803	10884	rs13418455-T	rs13418455	0	13418455	intergenic_variant	1		1E-6	6.0	(Modelling analysis)	1.06	[1.04-1.09]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	4q35.2	4	188940097	intergenic	LOC101930028 - LOC105377611	101930028	105377611		121612	113225	rs11731175-T	rs11731175	0	11731175	intergenic_variant	1		5E-6	5.301029995663981	(Modelling analysis)	1.06	[1.03-1.09]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	1q32.1	1	200991179	NR	KIF21B			23046			rs2297909-A	rs2297909	0	2297909	intron_variant	0		2E-6	5.698970004336019	(Modelling analysis)	1.06	[1.04-1.09]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	2q37.3	2	239191276	HDAC4, MGC16025	HDAC4			9759			rs3791556-A	rs3791556	0	3791556	intron_variant	0		8E-6	5.096910013008056	(Modelling analysis)	1.08	[1.04-1.11]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	6p21.33	6	30945681	NR	DPCR1			135656			rs3132581-G	rs3132581	0	3132581	intron_variant	0		2E-7	6.698970004336019	(Modelling analysis)			NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	6p21.32	6	32945469	NR	HLA-DMB - HLA-DMA	3109	3108		4399	3145	rs1480380-C	rs1480380	0	1480380	intron_variant	1	0.908	6E-7	6.221848749616356	(Modelling analysis)			NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	9p24.3	9	2194227	SMARCA2	LOC107987043			107987043			rs4741652-T	rs4741652	0	4741652	downstream_gene_variant	0	NR	7E-6	5.154901959985743	(Modelling analysis)	1.07	[1.04-1.12]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	10q21.2	10	60462349	ANK3	ANK3			288			rs10994359-C	rs10994359	0	10994359	intron_variant	0	NR	3E-9	8.522878745280337	(5 degree of freedom test)	1.081	[1.03-1.13]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	12p13.33	12	2236129	DCP1B, CACNA1C	CACNA1C			775			rs1006737-?	rs1006737	0	1006737	intron_variant	0	NR	5E-9	8.301029995663981	(5 degree of freedom test)	1.071	[1.05-1.10]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	6p22.1	6	30064745	MHC region	ZNRD1			30834			rs8321-?	rs8321	0	8321	3_prime_UTR_variant	0	NR	8E-9	8.096910013008056	(5 degree of freedom test)	1.081	[1.04-1.12]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	1p36.23	1	8362616	SLC45A1, RERE, ENO1	RERE			473			rs2252865-T	rs2252865	0	2252865	intron_variant	0	NR	5E-7	6.301029995663981	(5 degree of freedom test)	1.03	[1.00-1.06]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	19q13.41	19	51991525	NR	ZNF615			284370			rs1715-T	rs1715	0	1715	3_prime_UTR_variant	0	NR	6E-7	6.221848749616356	(5 degree of freedom test)	1.41	[1.29-1.53]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	1p31.1	1	78772330	IFI44L, IFI44	LOC652549 - ADGRL4	652549	64123		21474	117434	rs4650608-T	rs4650608	0	4650608	intergenic_variant	1	NR	1E-6	6.0	(5 degree of freedom test)	1.06	[1.03-1.09]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	8p12	8	34269430	intergenic	LOC105379365 - RPL10AP3	105379365	137107		41808	53530	rs6990255-T	rs6990255	0	6990255	intron_variant	1	NR	2E-6	5.698970004336019	(5 degree of freedom test)	1.146	[1.09-1.20]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	3p22.2	3	36814539	NR	LOC105377030 - LOC105377031	105377030	105377031		30254	4744	rs9834970-C	rs9834970	0	9834970	downstream_gene_variant	1	NR	2E-6	5.698970004336019	(5 degree of freedom test)	1.051	[1.03-1.07]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	8q21.3	8	88748082	MMP16	LOC105375629 - LOC105375631	105375629	105375631		148458	58338	rs7004633-?	rs7004633	0	7004633	intergenic_variant	1	0.184	3E-8	7.522878745280337	(Modelling analysis)			NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	7q21.11	7	84143099	SEMA3A	SEMA3A			10371			rs447-C	rs447	0	447	intron_variant	0	NR	4E-6	5.3979400086720375	(5 degree of freedom test)	1.025	[1.00-1.05]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	7p22.3	7	2238591	NR	FTSJ2			29960			rs7799006-C	rs7799006	0	7799006	non_coding_transcript_exon_variant	0	NR	5E-6	5.301029995663981	(5 degree of freedom test)	1.059	[1.03-1.08]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	21q21.3	21	29640839	GRIK1	GRIK1			2897			rs363598-C	rs363598	0	363598	intron_variant	0	NR	5E-6	5.301029995663981	(5 degree of freedom test)	1.006	[0.98-1.03]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	2q37.1	2	232871534	NR	C2orf82			389084			rs2675968-T	rs2675968	0	2675968	intron_variant	0	NR	5E-6	5.301029995663981	(5 degree of freedom test)	1.016	[0.99-1.04]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	10q22.3	10	79193379	ZMIZ1	ZMIZ1			57178			rs703970-C	rs703970	0	703970	intron_variant	0	NR	5E-6	5.301029995663981	(5 degree of freedom test)	1.01	[0.99-1.03]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	11q23.3	11	118470934	NR	KMT2A			4297			rs7948661-C	rs7948661	0	7948661	intron_variant	0	NR	5E-6	5.301029995663981	(5 degree of freedom test)	1.05	[1.00-1.10]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	11p14.3	11	22291020	ANO5, SLC17A6	ANO5 - SLC17A6	203859	57084		7653	47101	rs11827962-C	rs11827962	0	11827962	intron_variant	1	NR	6E-6	5.221848749616356	(5 degree of freedom test)	1.044	[0.94-1.15]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	20p13	20	4371457	intergenic	ADRA1D - LOC105372510	146	105372510		122445	192812	rs159788-G	rs159788	0	159788	intergenic_variant	1	NR	7E-6	5.154901959985743	(5 degree of freedom test)	1.012	[0.97-1.05]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	2p16.3	2	48422566	NR	FOXN2 - PPP1R21	3344	129285		43271	18203	rs7565792-C	rs7565792	0	7565792	intergenic_variant	1	NR	7E-6	5.154901959985743	(5 degree of freedom test)	1.03	[1.00-1.06]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	1q21.2	1	150351808	NR	PRPF3			9129			rs11587682-C	rs11587682	0	11587682	intron_variant	0	NR	7E-6	5.154901959985743	(5 degree of freedom test)	1.086	[1.05-1.12]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	2q32.1	2	184668853	ZNF804A	ZNF804A			91752			rs7597593-T	rs7597593	0	7597593	intron_variant	0	NR	8E-6	5.096910013008056	(5 degree of freedom test)	1.055	[1.03-1.08]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	2q23.2	2	149008736	KIF5C, LYPD6B	KIF5C			3800			rs6435387-G	rs6435387	0	6435387	intron_variant	0	NR	8E-6	5.096910013008056	(5 degree of freedom test)	1.129	[1.06-1.19]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	9p21.3	9	22819577	intergenic	LINC01239			441389			rs7849973-?	rs7849973	0	7849973	intron_variant	0	NR	8E-6	5.096910013008056	(5 degree of freedom test)	1.05	[1.02-1.08]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	7q33	7	136461788	intergenic	LOC105375523 - LOC100421642	105375523	100421642		22263	24251	rs10250997-C	rs10250997	0	10250997	intergenic_variant	1	NR	8E-6	5.096910013008056	(5 degree of freedom test)	1.03	[0.99-1.07]	NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	10q21.2	10	60519366	ANK3	ANK3			288			rs10994397-?	rs10994397	0	10994397	intron_variant	0	0.065	7E-9	8.154901959985743				NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	11q14.1	11	79366149	ODZ4	TENM4			26011			rs12576775-?	rs12576775	0	12576775	intron_variant	0	0.175	4E-8	7.3979400086720375	(Modelling analysis)			NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	6p22.1	6	30206354	MHC region	TRIM26			7726			rs2021722-?	rs2021722	0	2021722	intron_variant	0	0.789	2E-12	11.698970004336019	(Modelling analysis)			NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	18q21.2	18	55084786	CCDC68	LOC105372125			105372125			rs12966547-?	rs12966547	0	12966547	regulatory_region_variant	0	0.588	3E-10	9.522878745280337	(Modelling analysis)			NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	10q24.32	10	103016151	CNNM2	CNNM2			54805			rs7914558-?	rs7914558	0	7914558	intron_variant	0	0.587	2E-9	8.698970004336019	(Modelling analysis)			NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	10q24.33	10	103146454	NT5C2	NT5C2			22978			rs11191580-?	rs11191580	0	11191580	intron_variant	0	0.911	1E-8	8.0	(Modelling analysis)			NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	8p23.2	8	4323322	CSMD1	CSMD1			64478			rs10503253-?	rs10503253	0	10503253	intron_variant	0	0.193	4E-8	7.3979400086720375	(Modelling analysis)			NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	2q32.3	2	193119895	PCGEM1	LOC107985969			107985969			rs17662626-?	rs17662626	0	17662626	intergenic_variant	0	0.915	5E-8	7.301029995663981	(Modelling analysis)			NR [1252901] (imputed)	N
2013-06-06	23453885	Smoller JW	2013-02-27	Lancet	www.ncbi.nlm.nih.gov/pubmed/23453885	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	6,990 European ancestry Bipolar disorder cases, 9,227 European ancestry Major depressive disorder cases, 9,379 European ancestry Schizophrenia cases, 161 European ancestry Autism spectrum disorder cases, 4,788 European ancestry Autism spectrum disorder trio cases, 840 European ancestry Attention deficit-hyperactivity disorder cases, 1,947 European ancestry Attention defcit-hyperactivity disorder trio cases, 27,888 European ancestry controls	NA	11q24.2	11	125591814	STT3A	LOC105369550			105369550			rs548181-?	rs548181	0	548181	5_prime_UTR_variant	0	0.884	9E-7	6.045757490560675	(Modelling analysis)			NR [1252901] (imputed)	N
2010-09-22	20713499	Huang J	2010-08-16	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20713499	Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.	Schizophrenia, bipolar disorder and depression (combined)	402 European ancestry schizophrenia cases, 1,021 European ancestry bipolar I cases, 493 European ancestry bipolar II cases, 1,210 European ancestry MDD cases, 1,060 European ancestry controls	NA	11p15.4	11	10369034	ADM	CAND1.11			100130460			rs6484218-A	rs6484218	0	6484218	intron_variant	0	0.14	4E-8	7.3979400086720375				Affymetrix, Perlegen [1574154] (imputed)	N
2010-09-22	20713499	Huang J	2010-08-16	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20713499	Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.	Schizophrenia, bipolar disorder and depression (combined)	402 European ancestry schizophrenia cases, 1,021 European ancestry bipolar I cases, 493 European ancestry bipolar II cases, 1,210 European ancestry MDD cases, 1,060 European ancestry controls	NA	22q12.1	22	26007633	MYO18B	MYO18B			84700			rs1001021-A	rs1001021	0	1001021	intron_variant	0	0.02	2E-6	5.698970004336019				Affymetrix, Perlegen [1574154] (imputed)	N
2010-09-22	20713499	Huang J	2010-08-16	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20713499	Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.	Schizophrenia, bipolar disorder and depression (combined)	402 European ancestry schizophrenia cases, 1,021 European ancestry bipolar I cases, 493 European ancestry bipolar II cases, 1,210 European ancestry MDD cases, 1,060 European ancestry controls	NA	13q12.11	13	20635373	IFT88	IFT88			8100			rs7326068-A	rs7326068	0	7326068	intron_variant	0	0.19	3E-6	5.522878745280337				Affymetrix, Perlegen [1574154] (imputed)	N
2010-09-22	20713499	Huang J	2010-08-16	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20713499	Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.	Schizophrenia, bipolar disorder and depression (combined)	402 European ancestry schizophrenia cases, 1,021 European ancestry bipolar I cases, 493 European ancestry bipolar II cases, 1,210 European ancestry MDD cases, 1,060 European ancestry controls	NA	9q21.13	9	73149649	ANXA1	LOC105376081 - ANXA1	105376081	301		35733	2082	rs3758354-C	rs3758354	0	3758354	upstream_gene_variant	1	0.03	3E-6	5.522878745280337				Affymetrix, Perlegen [1574154] (imputed)	N
2010-09-22	20713499	Huang J	2010-08-16	Am J Psychiatry	www.ncbi.nlm.nih.gov/pubmed/20713499	Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.	Schizophrenia, bipolar disorder and depression (combined)	402 European ancestry schizophrenia cases, 1,021 European ancestry bipolar I cases, 493 European ancestry bipolar II cases, 1,210 European ancestry MDD cases, 1,060 European ancestry controls	NA	14q13.1	14	33007060	NPAS3	NPAS3			64067			rs4982029-A	rs4982029	0	4982029	intron_variant	0	0.02	4E-6	5.3979400086720375				Affymetrix, Perlegen [1574154] (imputed)	N
2015-01-20	24964207	Mullins N	2014-06-25	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/24964207	Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study.	Suicide attempts in depression or bipolar disorder	426 European ancestry cases, 2,844 European ancestry controls	NA	7q36.1	7	150339575	RARRES2	RARRES2			5919			rs17173608-G	rs17173608	0	17173608	intron_variant	0	0.058	2E-7	6.698970004336019		1.93	[1.69-2.19]	Illumina [up to 503016]	N
2015-01-20	24964207	Mullins N	2014-06-25	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/24964207	Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study.	Suicide attempts in depression or bipolar disorder	426 European ancestry cases, 2,844 European ancestry controls	NA	4p15.32	4	15993502	PROM1	PROM1			8842			rs17387100-G	rs17387100	0	17387100	intron_variant	0	0.078	8E-7	6.096910013008056		1.76	[1.54-1.99]	Illumina [up to 503016]	N
2015-01-20	24964207	Mullins N	2014-06-25	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/24964207	Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study.	Suicide attempts in depression or bipolar disorder	426 European ancestry cases, 2,844 European ancestry controls	NA	11q23.2	11	113249490	NCAM1	NCAM1			4684			rs3781878-?	rs3781878	0	3781878	intron_variant	0	0.728	2E-6	5.698970004336019		1.54	[1.2-2.08]	Illumina [up to 503016]	N
2015-01-20	24964207	Mullins N	2014-06-25	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/24964207	Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study.	Suicidal ideation in depression or bipolar disorder	237 European ancestry cases, 510 European ancestry controls	NA	12q14.3	12	66422359	NR	GRIP1			23426			rs10748045-G	rs10748045	0	10748045	intron_variant	0	0.354	1E-6	6.0		1.78	[1.41-2.25]	Illumina [494742]	N
2016-06-15	25944848	Athanasiu L	2015-05-05	J Psychopharmacol	www.ncbi.nlm.nih.gov/pubmed/25944848	Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs.	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Up to 320 European ancestry cases	NA	7q31.1	7	111871082	intergenic	DOCK4			9732			rs17158930-G	rs17158930	0	17158930	intron_variant	0	0.193	3E-7	6.522878745280337		0.3082	[NR] unit decrease	Affymetrix [686595]	N
2016-06-15	25944848	Athanasiu L	2015-05-05	J Psychopharmacol	www.ncbi.nlm.nih.gov/pubmed/25944848	Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs.	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Up to 185 European ancestry cases	NA	8q13.2	8	68961217	LOC100505718	LOC100505718			100505718			rs16935279-C	rs16935279	0	16935279	intron_variant	0	0.014	5E-10	9.301029995663981		0.7918	[NR] unit decrease	Affymetrix [686595]	N
2016-06-15	25944848	Athanasiu L	2015-05-05	J Psychopharmacol	www.ncbi.nlm.nih.gov/pubmed/25944848	Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs.	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Up to 185 European ancestry cases	NA	12p12.3	12	19040597	PLEKHA5	LOC107984527			107984527			rs11829119-C	rs11829119	0	11829119	intergenic_variant	0	0.063	1E-7	7.0		0.4991	[NR] unit decrease	Affymetrix [686595]	N
2016-06-15	25944848	Athanasiu L	2015-05-05	J Psychopharmacol	www.ncbi.nlm.nih.gov/pubmed/25944848	Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs.	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Up to 185 European ancestry cases	NA	13q22.3	13	76889874	intergenic	KCTD12 - BTF3P11	115207	690		3469	38577	rs17066873-C	rs17066873	0	17066873	non_coding_transcript_exon_variant	1	0.039	2E-7	6.698970004336019		0.9277	[NR] unit decrease	Affymetrix [686595]	N
2016-06-15	25944848	Athanasiu L	2015-05-05	J Psychopharmacol	www.ncbi.nlm.nih.gov/pubmed/25944848	Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs.	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Up to 185 European ancestry cases	NA	5q15	5	95647825	RFESD	RFESD			317671			rs17790731-A	rs17790731	0	17790731	5_prime_UTR_variant	0	0.034	2E-7	6.698970004336019		0.531	[NR] unit decrease	Affymetrix [686595]	N
2016-06-15	25944848	Athanasiu L	2015-05-05	J Psychopharmacol	www.ncbi.nlm.nih.gov/pubmed/25944848	Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs.	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Up to 829 European ancestry cases	NA	1q42.3	1	234897489	intergenic	LOC107985365 - RN7SL668P	107985365	106479466		20594	6697	rs6586354-A	rs6586354	0	6586354	intergenic_variant	1	0.226	1E-7	7.0		0.2802	[NR] unit decrease	Affymetrix [686595]	N
2016-06-15	25944848	Athanasiu L	2015-05-05	J Psychopharmacol	www.ncbi.nlm.nih.gov/pubmed/25944848	Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs.	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Up to 829 European ancestry cases	NA	7q21.11	7	81207393	intergenic	LOC100420647 - EIF4EP4	100420647	100421455		15384	255643	rs17154917-T	rs17154917	0	17154917	intergenic_variant	1	0.022	3E-7	6.522878745280337		0.6656	[NR] unit decrease	Affymetrix [686595]	N
2016-06-15	25944848	Athanasiu L	2015-05-05	J Psychopharmacol	www.ncbi.nlm.nih.gov/pubmed/25944848	Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs.	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Up to 829 European ancestry cases	NA	2q37.3	2	241081801	SNED1	SNED1, MTERF4			25992, 130916			rs2302045-T	rs2302045	0	2302045	splice_region_variant	0	0.067	4E-7	6.3979400086720375		0.4064	[NR] unit decrease	Affymetrix [686595]	N
2016-06-15	25944848	Athanasiu L	2015-05-05	J Psychopharmacol	www.ncbi.nlm.nih.gov/pubmed/25944848	Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs.	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Up to 290 European ancestry cases	NA	3p24.1	3	30453840	intergenic	LOC101927995, LOC105377013			101927995, 105377013			rs9862857-C	rs9862857	0	9862857	intergenic_variant	0	NR	6E-8	7.221848749616356		0.7386	[NR] unit decrease	Affymetrix [686595]	N
2016-06-15	25944848	Athanasiu L	2015-05-05	J Psychopharmacol	www.ncbi.nlm.nih.gov/pubmed/25944848	Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs.	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Up to 290 European ancestry cases	NA	8p12	8	32840440	intergenic	NRG1 - RNU6-663P	3084	106481391		68724	71053	rs17673138-C	rs17673138	0	17673138	intergenic_variant	1	NR	6E-8	7.221848749616356		0.4143	[NR] unit decrease	Affymetrix [686595]	N
2016-06-15	25944848	Athanasiu L	2015-05-05	J Psychopharmacol	www.ncbi.nlm.nih.gov/pubmed/25944848	Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs.	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Up to 290 European ancestry cases	NA	9p21.1	9	28752486	LINGO2	LINGO2			158038			rs10968749-G	rs10968749	0	10968749	intergenic_variant	0	NR	2E-7	6.698970004336019		0.8345	[NR] unit decrease	Affymetrix [686595]	N
2016-06-15	25944848	Athanasiu L	2015-05-05	J Psychopharmacol	www.ncbi.nlm.nih.gov/pubmed/25944848	Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs.	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Up to 290 European ancestry cases	NA	19p12	19	19948684	intergenic	BNIP3P12			100421703			rs10405744-A	rs10405744	0	10405744	intron_variant	0	NR	2E-7	6.698970004336019		0.5736	[NR] unit decrease	Affymetrix [686595]	N
